| ENSG00000104691.10 |
Methotrexate |
Breast invasive carcinoma |
0.027533647 |
Resistant |
| ENSG00000160336.10 |
Methotrexate |
Breast invasive carcinoma |
0.015977063 |
Resistant |
| ENSG00000167912.5 |
Methotrexate |
Breast invasive carcinoma |
0.024711919 |
Resistant |
| ENSG00000170919.11 |
Methotrexate |
Breast invasive carcinoma |
0.001529097 |
Resistant |
| ENSG00000173867.8 |
Methotrexate |
Breast invasive carcinoma |
0.022014168 |
Resistant |
| ENSG00000185186.4 |
Methotrexate |
Breast invasive carcinoma |
0.048267063 |
Resistant |
| ENSG00000186594.8 |
Methotrexate |
Breast invasive carcinoma |
0.044710164 |
Resistant |
| ENSG00000203279.3 |
Methotrexate |
Breast invasive carcinoma |
0.021612248 |
Resistant |
| ENSG00000203327.2 |
Methotrexate |
Breast invasive carcinoma |
0.046474806 |
Resistant |
| ENSG00000203875.6 |
Methotrexate |
Breast invasive carcinoma |
0.017148537 |
Resistant |
| ENSG00000204860.4 |
Methotrexate |
Breast invasive carcinoma |
0.024533349 |
Resistant |
| ENSG00000219665.4 |
Methotrexate |
Breast invasive carcinoma |
0.047423973 |
Resistant |
| ENSG00000223598.1 |
Methotrexate |
Breast invasive carcinoma |
0.038538103 |
Resistant |
| ENSG00000223695.1 |
Methotrexate |
Breast invasive carcinoma |
0.034479606 |
Resistant |
| ENSG00000223839.3 |
Methotrexate |
Breast invasive carcinoma |
0.021869901 |
Resistant |
| ENSG00000224116.2 |
Methotrexate |
Breast invasive carcinoma |
0.038504645 |
Resistant |
| ENSG00000224905.2 |
Methotrexate |
Breast invasive carcinoma |
0.038978875 |
Resistant |
| ENSG00000225760.1 |
Methotrexate |
Breast invasive carcinoma |
0.044002712 |
Resistant |
| ENSG00000227060.2 |
Methotrexate |
Breast invasive carcinoma |
0.045039863 |
Resistant |
| ENSG00000227210.1 |
Methotrexate |
Breast invasive carcinoma |
0.038468804 |
Resistant |
| ENSG00000227215.1 |
Methotrexate |
Breast invasive carcinoma |
0.017069335 |
Resistant |
| ENSG00000228214.2 |
Methotrexate |
Breast invasive carcinoma |
0.030496872 |
Resistant |
| ENSG00000228485.1 |
Methotrexate |
Breast invasive carcinoma |
0.024203596 |
Resistant |
| ENSG00000228604.3 |
Methotrexate |
Breast invasive carcinoma |
0.04481171 |
Resistant |
| ENSG00000229463.2 |
Methotrexate |
Breast invasive carcinoma |
0.03885918 |
Resistant |
| ENSG00000229498.1 |
Methotrexate |
Breast invasive carcinoma |
0.016498944 |
Resistant |
| ENSG00000229852.2 |
Methotrexate |
Breast invasive carcinoma |
0.003110403 |
Resistant |
| ENSG00000229915.1 |
Methotrexate |
Breast invasive carcinoma |
0.014272848 |
Resistant |
| ENSG00000229956.5 |
Methotrexate |
Breast invasive carcinoma |
0.009068249 |
Resistant |
| ENSG00000230024.1 |
Methotrexate |
Breast invasive carcinoma |
0.035108464 |
Resistant |
| ENSG00000230074.1 |
Methotrexate |
Breast invasive carcinoma |
0.034396006 |
Resistant |
| ENSG00000230084.1 |
Methotrexate |
Breast invasive carcinoma |
0.015369733 |
Resistant |
| ENSG00000230499.1 |
Methotrexate |
Breast invasive carcinoma |
0.043634769 |
Resistant |
| ENSG00000230623.2 |
Methotrexate |
Breast invasive carcinoma |
0.047260482 |
Resistant |
| ENSG00000230658.1 |
Methotrexate |
Breast invasive carcinoma |
0.014649616 |
Resistant |
| ENSG00000230836.1 |
Methotrexate |
Breast invasive carcinoma |
0.01723972 |
Resistant |
| ENSG00000231742.1 |
Methotrexate |
Breast invasive carcinoma |
0.001872885 |
Resistant |
| ENSG00000232295.3 |
Methotrexate |
Breast invasive carcinoma |
0.047114988 |
Resistant |
| ENSG00000232480.1 |
Methotrexate |
Breast invasive carcinoma |
0.033598702 |
Resistant |
| ENSG00000232642.1 |
Methotrexate |
Breast invasive carcinoma |
0.035812967 |
Resistant |
| ENSG00000232977.2 |
Methotrexate |
Breast invasive carcinoma |
0.038704908 |
Resistant |
| ENSG00000233237.2 |
Methotrexate |
Breast invasive carcinoma |
0.046742061 |
Resistant |
| ENSG00000233244.2 |
Methotrexate |
Breast invasive carcinoma |
0.029017423 |
Resistant |
| ENSG00000235387.1 |
Methotrexate |
Breast invasive carcinoma |
0.02770305 |
Resistant |
| ENSG00000235427.1 |
Methotrexate |
Breast invasive carcinoma |
0.007129467 |
Resistant |
| ENSG00000235635.1 |
Methotrexate |
Breast invasive carcinoma |
0.042017328 |
Resistant |
| ENSG00000235927.2 |
Methotrexate |
Breast invasive carcinoma |
0.023855791 |
Resistant |
| ENSG00000236591.1 |
Methotrexate |
Breast invasive carcinoma |
0.01783113 |
Resistant |
| ENSG00000236869.1 |
Methotrexate |
Breast invasive carcinoma |
0.013172368 |
Resistant |
| ENSG00000236914.3 |
Methotrexate |
Breast invasive carcinoma |
0.024487628 |
Resistant |
| ENSG00000237517.4 |
Methotrexate |
Breast invasive carcinoma |
0.030680441 |
Resistant |
| ENSG00000239636.1 |
Methotrexate |
Breast invasive carcinoma |
0.024876497 |
Resistant |
| ENSG00000239828.2 |
Methotrexate |
Breast invasive carcinoma |
0.03388946 |
Resistant |
| ENSG00000241316.2 |
Methotrexate |
Breast invasive carcinoma |
0.00293693 |
Resistant |
| ENSG00000241593.1 |
Methotrexate |
Breast invasive carcinoma |
0.024063611 |
Resistant |
| ENSG00000242104.3 |
Methotrexate |
Breast invasive carcinoma |
0.004229595 |
Resistant |
| ENSG00000242516.1 |
Methotrexate |
Breast invasive carcinoma |
0.04496572 |
Resistant |
| ENSG00000245573.3 |
Methotrexate |
Breast invasive carcinoma |
0.028593934 |
Resistant |
| ENSG00000245910.4 |
Methotrexate |
Breast invasive carcinoma |
0.000838796 |
Resistant |
| ENSG00000246130.1 |
Methotrexate |
Breast invasive carcinoma |
0.003263659 |
Resistant |
| ENSG00000248275.1 |
Methotrexate |
Breast invasive carcinoma |
0.017001458 |
Resistant |
| ENSG00000248559.1 |
Methotrexate |
Breast invasive carcinoma |
0.004068026 |
Resistant |
| ENSG00000248724.2 |
Methotrexate |
Breast invasive carcinoma |
0.022230867 |
Resistant |
| ENSG00000249207.1 |
Methotrexate |
Breast invasive carcinoma |
0.014202754 |
Resistant |
| ENSG00000249898.3 |
Methotrexate |
Breast invasive carcinoma |
0.003457359 |
Resistant |
| ENSG00000250081.1 |
Methotrexate |
Breast invasive carcinoma |
0.02194524 |
Resistant |
| ENSG00000250222.1 |
Methotrexate |
Breast invasive carcinoma |
0.017687146 |
Resistant |
| ENSG00000250303.2 |
Methotrexate |
Breast invasive carcinoma |
0.023738636 |
Resistant |
| ENSG00000250948.1 |
Methotrexate |
Breast invasive carcinoma |
0.012088308 |
Resistant |
| ENSG00000251138.2 |
Methotrexate |
Breast invasive carcinoma |
0.032180231 |
Resistant |
| ENSG00000251391.4 |
Methotrexate |
Breast invasive carcinoma |
0.042980517 |
Resistant |
| ENSG00000253476.1 |
Methotrexate |
Breast invasive carcinoma |
0.020117943 |
Resistant |
| ENSG00000253948.1 |
Methotrexate |
Breast invasive carcinoma |
0.006751629 |
Resistant |
| ENSG00000253982.1 |
Methotrexate |
Breast invasive carcinoma |
0.043192347 |
Resistant |
| ENSG00000254038.1 |
Methotrexate |
Breast invasive carcinoma |
0.034358953 |
Resistant |
| ENSG00000254461.1 |
Methotrexate |
Breast invasive carcinoma |
0.004144195 |
Resistant |
| ENSG00000254710.1 |
Methotrexate |
Breast invasive carcinoma |
0.020078257 |
Resistant |
| ENSG00000254855.1 |
Methotrexate |
Breast invasive carcinoma |
0.028589799 |
Resistant |
| ENSG00000255090.1 |
Methotrexate |
Breast invasive carcinoma |
0.04252672 |
Resistant |
| ENSG00000255094.1 |
Methotrexate |
Breast invasive carcinoma |
0.034709647 |
Resistant |
| ENSG00000255197.1 |
Methotrexate |
Breast invasive carcinoma |
0.005211337 |
Resistant |
| ENSG00000255495.1 |
Methotrexate |
Breast invasive carcinoma |
0.041839356 |
Resistant |
| ENSG00000255557.1 |
Methotrexate |
Breast invasive carcinoma |
0.04035229 |
Resistant |
| ENSG00000256250.1 |
Methotrexate |
Breast invasive carcinoma |
0.023466494 |
Resistant |
| ENSG00000256268.1 |
Methotrexate |
Breast invasive carcinoma |
0.042046781 |
Resistant |
| ENSG00000257698.1 |
Methotrexate |
Breast invasive carcinoma |
0.015234527 |
Resistant |
| ENSG00000258952.1 |
Methotrexate |
Breast invasive carcinoma |
0.027845609 |
Resistant |
| ENSG00000259146.2 |
Methotrexate |
Breast invasive carcinoma |
0.047947283 |
Resistant |
| ENSG00000259645.1 |
Methotrexate |
Breast invasive carcinoma |
0.048869214 |
Resistant |
| ENSG00000259744.1 |
Methotrexate |
Breast invasive carcinoma |
0.049841439 |
Resistant |
| ENSG00000259863.1 |
Methotrexate |
Breast invasive carcinoma |
0.014199752 |
Resistant |
| ENSG00000260037.1 |
Methotrexate |
Breast invasive carcinoma |
0.047393096 |
Resistant |
| ENSG00000260060.1 |
Methotrexate |
Breast invasive carcinoma |
0.019752392 |
Resistant |
| ENSG00000260065.1 |
Methotrexate |
Breast invasive carcinoma |
0.033826221 |
Resistant |
| ENSG00000260196.1 |
Methotrexate |
Breast invasive carcinoma |
0.045305742 |
Resistant |
| ENSG00000260248.1 |
Methotrexate |
Breast invasive carcinoma |
0.039662836 |
Resistant |
| ENSG00000260329.1 |
Methotrexate |
Breast invasive carcinoma |
0.016132085 |
Resistant |
| ENSG00000260787.1 |
Methotrexate |
Breast invasive carcinoma |
0.025115897 |
Resistant |
| ENSG00000260804.2 |
Methotrexate |
Breast invasive carcinoma |
0.017684803 |
Resistant |
| ENSG00000260833.2 |
Methotrexate |
Breast invasive carcinoma |
0.034644146 |
Resistant |
| ENSG00000260910.1 |
Methotrexate |
Breast invasive carcinoma |
0.044601643 |
Resistant |
| ENSG00000260920.1 |
Methotrexate |
Breast invasive carcinoma |
0.008094233 |
Resistant |
| ENSG00000260931.1 |
Methotrexate |
Breast invasive carcinoma |
0.044253561 |
Resistant |
| ENSG00000261126.3 |
Methotrexate |
Breast invasive carcinoma |
0.018034453 |
Resistant |
| ENSG00000261280.2 |
Methotrexate |
Breast invasive carcinoma |
0.042906922 |
Resistant |
| ENSG00000261451.1 |
Methotrexate |
Breast invasive carcinoma |
0.023933083 |
Resistant |
| ENSG00000261618.1 |
Methotrexate |
Breast invasive carcinoma |
0.031048676 |
Resistant |
| ENSG00000261801.1 |
Methotrexate |
Breast invasive carcinoma |
0.032023793 |
Resistant |
| ENSG00000262115.1 |
Methotrexate |
Breast invasive carcinoma |
0.012987152 |
Resistant |
| ENSG00000262434.1 |
Methotrexate |
Breast invasive carcinoma |
0.036513202 |
Resistant |
| ENSG00000262769.1 |
Methotrexate |
Breast invasive carcinoma |
0.025923729 |
Resistant |
| ENSG00000262888.1 |
Methotrexate |
Breast invasive carcinoma |
0.024162355 |
Resistant |
| ENSG00000263069.1 |
Methotrexate |
Breast invasive carcinoma |
0.030152849 |
Resistant |
| ENSG00000263766.1 |
Methotrexate |
Breast invasive carcinoma |
0.039997007 |
Resistant |
| ENSG00000264365.1 |
Methotrexate |
Breast invasive carcinoma |
0.042322869 |
Resistant |
| ENSG00000265242.1 |
Methotrexate |
Breast invasive carcinoma |
0.019765304 |
Resistant |
| ENSG00000266912.1 |
Methotrexate |
Breast invasive carcinoma |
0.033186495 |
Resistant |
| ENSG00000266930.2 |
Methotrexate |
Breast invasive carcinoma |
0.002687428 |
Resistant |
| ENSG00000266983.1 |
Methotrexate |
Breast invasive carcinoma |
0.035080174 |
Resistant |
| ENSG00000267108.1 |
Methotrexate |
Breast invasive carcinoma |
0.039340594 |
Resistant |
| ENSG00000267169.1 |
Methotrexate |
Breast invasive carcinoma |
0.047882431 |
Resistant |
| ENSG00000267939.1 |
Methotrexate |
Breast invasive carcinoma |
0.02132833 |
Resistant |
| ENSG00000268392.1 |
Methotrexate |
Breast invasive carcinoma |
0.037212047 |
Resistant |
| ENSG00000268812.2 |
Methotrexate |
Breast invasive carcinoma |
0.00777784 |
Resistant |
| ENSG00000268836.1 |
Methotrexate |
Breast invasive carcinoma |
0.044067622 |
Resistant |
| ENSG00000268895.1 |
Methotrexate |
Breast invasive carcinoma |
0.007222369 |
Resistant |
| ENSG00000269293.2 |
Methotrexate |
Breast invasive carcinoma |
0.032392204 |
Resistant |
| ENSG00000269600.1 |
Methotrexate |
Breast invasive carcinoma |
0.009901834 |
Resistant |
| ENSG00000269696.1 |
Methotrexate |
Breast invasive carcinoma |
0.041525575 |
Resistant |
| ENSG00000269899.1 |
Methotrexate |
Breast invasive carcinoma |
0.021631406 |
Resistant |
| ENSG00000269966.1 |
Methotrexate |
Breast invasive carcinoma |
0.039381433 |
Resistant |
| ENSG00000270062.1 |
Methotrexate |
Breast invasive carcinoma |
0.04535753 |
Resistant |
| ENSG00000270143.1 |
Methotrexate |
Breast invasive carcinoma |
0.046500363 |
Resistant |
| ENSG00000271743.1 |
Methotrexate |
Breast invasive carcinoma |
0.008929306 |
Resistant |
| ENSG00000271755.1 |
Methotrexate |
Breast invasive carcinoma |
0.004611038 |
Resistant |
| ENSG00000271857.1 |
Methotrexate |
Breast invasive carcinoma |
0.021145234 |
Resistant |
| ENSG00000271911.1 |
Methotrexate |
Breast invasive carcinoma |
0.04280974 |
Resistant |
| ENSG00000271927.1 |
Methotrexate |
Breast invasive carcinoma |
0.004881767 |
Resistant |
| ENSG00000271948.1 |
Methotrexate |
Breast invasive carcinoma |
0.00213027 |
Resistant |
| ENSG00000272005.1 |
Methotrexate |
Breast invasive carcinoma |
0.008990138 |
Resistant |
| ENSG00000272040.1 |
Methotrexate |
Breast invasive carcinoma |
0.016328294 |
Resistant |
| ENSG00000272077.1 |
Methotrexate |
Breast invasive carcinoma |
0.007252783 |
Resistant |
| ENSG00000272316.1 |
Methotrexate |
Breast invasive carcinoma |
0.01981373 |
Resistant |
| ENSG00000272695.1 |
Methotrexate |
Breast invasive carcinoma |
0.019073127 |
Resistant |
| ENSG00000272788.1 |
Methotrexate |
Breast invasive carcinoma |
0.029923982 |
Resistant |
| ENSG00000272870.1 |
Methotrexate |
Breast invasive carcinoma |
0.041638677 |
Resistant |
| ENSG00000272904.1 |
Methotrexate |
Breast invasive carcinoma |
0.012633813 |
Resistant |
| ENSG00000272949.1 |
Methotrexate |
Breast invasive carcinoma |
0.047731088 |
Resistant |
| ENSG00000272983.1 |
Methotrexate |
Breast invasive carcinoma |
0.045176845 |
Resistant |
| ENSG00000273007.1 |
Methotrexate |
Breast invasive carcinoma |
0.02760768 |
Resistant |
| ENSG00000273203.1 |
Methotrexate |
Breast invasive carcinoma |
0.045938114 |
Resistant |
| ENSG00000273350.1 |
Methotrexate |
Breast invasive carcinoma |
0.038339335 |
Resistant |
| ENSG00000273352.1 |
Methotrexate |
Breast invasive carcinoma |
0.014771307 |
Resistant |
| ENSG00000273402.1 |
Methotrexate |
Breast invasive carcinoma |
0.010626205 |
Resistant |
| ENSG00000203645.2 |
Methotrexate |
Colon adenocarcinoma |
0.008040353 |
Resistant |
| ENSG00000225329.1 |
Methotrexate |
Colon adenocarcinoma |
0.016956468 |
Resistant |
| ENSG00000231704.1 |
Methotrexate |
Colon adenocarcinoma |
0.045741707 |
Resistant |
| ENSG00000233246.1 |
Methotrexate |
Colon adenocarcinoma |
0.002261396 |
Resistant |
| ENSG00000233930.3 |
Methotrexate |
Colon adenocarcinoma |
0.034013387 |
Resistant |
| ENSG00000235501.1 |
Methotrexate |
Colon adenocarcinoma |
0.031624808 |
Resistant |
| ENSG00000239508.1 |
Methotrexate |
Colon adenocarcinoma |
0.038564392 |
Resistant |
| ENSG00000241472.2 |
Methotrexate |
Colon adenocarcinoma |
0.017238396 |
Resistant |
| ENSG00000248846.2 |
Methotrexate |
Colon adenocarcinoma |
0.000839516 |
Resistant |
| ENSG00000250508.1 |
Methotrexate |
Colon adenocarcinoma |
0.038207881 |
Resistant |
| ENSG00000253111.1 |
Methotrexate |
Colon adenocarcinoma |
0.01288443 |
Resistant |
| ENSG00000253898.1 |
Methotrexate |
Colon adenocarcinoma |
0.016556724 |
Resistant |
| ENSG00000255052.3 |
Methotrexate |
Colon adenocarcinoma |
0.028518549 |
Resistant |
| ENSG00000255774.1 |
Methotrexate |
Colon adenocarcinoma |
0.047657145 |
Resistant |
| ENSG00000258689.1 |
Methotrexate |
Colon adenocarcinoma |
0.049179006 |
Resistant |
| ENSG00000260633.1 |
Methotrexate |
Colon adenocarcinoma |
0.033780737 |
Resistant |
| ENSG00000261712.1 |
Methotrexate |
Colon adenocarcinoma |
0.00584737 |
Resistant |
| ENSG00000263429.3 |
Methotrexate |
Colon adenocarcinoma |
0.046033785 |
Resistant |
| ENSG00000265091.1 |
Methotrexate |
Colon adenocarcinoma |
0.015895193 |
Resistant |
| ENSG00000266844.1 |
Methotrexate |
Colon adenocarcinoma |
0.014344753 |
Resistant |
| ENSG00000272079.1 |
Methotrexate |
Colon adenocarcinoma |
0.040924283 |
Resistant |
| ENSG00000272198.1 |
Methotrexate |
Colon adenocarcinoma |
0.028881518 |
Resistant |
| ENSG00000273174.1 |
Methotrexate |
Colon adenocarcinoma |
0.00159818 |
Resistant |
| ENSG00000172965.10 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040455264 |
Resistant |
| ENSG00000179743.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036433596 |
Resistant |
| ENSG00000185837.3 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014379892 |
Resistant |
| ENSG00000227492.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042931787 |
Resistant |
| ENSG00000228021.3 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037758298 |
Resistant |
| ENSG00000228852.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04605833 |
Resistant |
| ENSG00000231681.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003162764 |
Resistant |
| ENSG00000234871.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017517411 |
Resistant |
| ENSG00000235545.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012704787 |
Resistant |
| ENSG00000250132.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014574028 |
Resistant |
| ENSG00000267274.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044690188 |
Resistant |
| ENSG00000268912.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011700699 |
Resistant |
| ENSG00000270069.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048357859 |
Resistant |
| ENSG00000271978.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012351722 |
Resistant |
| ENSG00000229807.5 |
Methotrexate |
Esophageal cancer |
0.03208255 |
Resistant |
| ENSG00000234456.3 |
Methotrexate |
Esophageal cancer |
0.004043214 |
Resistant |
| ENSG00000257900.2 |
Methotrexate |
Esophageal cancer |
0.018375406 |
Resistant |
| ENSG00000258661.1 |
Methotrexate |
Esophageal cancer |
0.049367295 |
Resistant |
| ENSG00000265206.2 |
Methotrexate |
Esophageal cancer |
0.020840326 |
Resistant |
| ENSG00000270641.1 |
Methotrexate |
Esophageal cancer |
0.029601262 |
Resistant |
| ENSG00000172965.10 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.013118655 |
Resistant |
| ENSG00000182310.8 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.000192772 |
Resistant |
| ENSG00000184274.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.009483826 |
Resistant |
| ENSG00000188365.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.018494542 |
Resistant |
| ENSG00000197813.4 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.042434897 |
Resistant |
| ENSG00000203327.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.016426309 |
Resistant |
| ENSG00000206140.5 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.030644479 |
Resistant |
| ENSG00000214870.4 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.033494082 |
Resistant |
| ENSG00000215241.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.012823686 |
Resistant |
| ENSG00000215244.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.038042866 |
Resistant |
| ENSG00000215304.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.013539993 |
Resistant |
| ENSG00000223576.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.043719433 |
Resistant |
| ENSG00000223842.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.033275494 |
Resistant |
| ENSG00000223882.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.025518044 |
Resistant |
| ENSG00000224086.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.01178121 |
Resistant |
| ENSG00000224959.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.003699919 |
Resistant |
| ENSG00000224972.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.02227477 |
Resistant |
| ENSG00000225667.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.046931036 |
Resistant |
| ENSG00000225791.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.037518609 |
Resistant |
| ENSG00000227172.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.024744061 |
Resistant |
| ENSG00000227719.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.01183448 |
Resistant |
| ENSG00000227946.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.044440098 |
Resistant |
| ENSG00000228140.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.007664092 |
Resistant |
| ENSG00000228886.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.025949825 |
Resistant |
| ENSG00000228889.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.01185677 |
Resistant |
| ENSG00000229327.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.042955108 |
Resistant |
| ENSG00000229891.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.048345326 |
Resistant |
| ENSG00000230102.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.044533879 |
Resistant |
| ENSG00000230615.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.044296553 |
Resistant |
| ENSG00000230836.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.042836648 |
Resistant |
| ENSG00000231010.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.031274917 |
Resistant |
| ENSG00000231346.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.006505589 |
Resistant |
| ENSG00000232874.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.010272839 |
Resistant |
| ENSG00000233203.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.044262021 |
Resistant |
| ENSG00000233509.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.015686944 |
Resistant |
| ENSG00000233547.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.031281954 |
Resistant |
| ENSG00000233797.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.011415234 |
Resistant |
| ENSG00000233862.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.017300363 |
Resistant |
| ENSG00000234753.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.007243649 |
Resistant |
| ENSG00000235121.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.024385464 |
Resistant |
| ENSG00000235373.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.027138404 |
Resistant |
| ENSG00000235989.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.017684531 |
Resistant |
| ENSG00000236528.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.03525005 |
Resistant |
| ENSG00000236869.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.036212319 |
Resistant |
| ENSG00000237188.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.04923781 |
Resistant |
| ENSG00000237576.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.036245865 |
Resistant |
| ENSG00000241155.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.029541921 |
Resistant |
| ENSG00000243176.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.04750394 |
Resistant |
| ENSG00000243485.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.03610402 |
Resistant |
| ENSG00000245534.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.018706697 |
Resistant |
| ENSG00000246582.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.006385243 |
Resistant |
| ENSG00000248925.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.021553979 |
Resistant |
| ENSG00000249786.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.041996319 |
Resistant |
| ENSG00000250129.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.043730871 |
Resistant |
| ENSG00000250714.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.01087369 |
Resistant |
| ENSG00000251186.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.039761266 |
Resistant |
| ENSG00000251432.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.009164965 |
Resistant |
| ENSG00000251602.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.016794993 |
Resistant |
| ENSG00000253125.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.047423945 |
Resistant |
| ENSG00000253187.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.042967124 |
Resistant |
| ENSG00000253327.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.04544653 |
Resistant |
| ENSG00000253552.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.041415292 |
Resistant |
| ENSG00000253582.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.010146503 |
Resistant |
| ENSG00000253853.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.003389698 |
Resistant |
| ENSG00000253930.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.006281304 |
Resistant |
| ENSG00000256433.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.043630176 |
Resistant |
| ENSG00000256967.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.037944059 |
Resistant |
| ENSG00000257261.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.030437568 |
Resistant |
| ENSG00000257702.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.046780961 |
Resistant |
| ENSG00000257999.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.038578979 |
Resistant |
| ENSG00000258101.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.024122722 |
Resistant |
| ENSG00000258137.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.025912474 |
Resistant |
| ENSG00000258561.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.036670547 |
Resistant |
| ENSG00000259377.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.044251376 |
Resistant |
| ENSG00000259553.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.026495194 |
Resistant |
| ENSG00000260932.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.04694246 |
Resistant |
| ENSG00000260941.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.035744255 |
Resistant |
| ENSG00000261242.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.015607111 |
Resistant |
| ENSG00000261442.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.049119424 |
Resistant |
| ENSG00000261737.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.036984388 |
Resistant |
| ENSG00000261823.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.02250245 |
Resistant |
| ENSG00000261872.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.038345031 |
Resistant |
| ENSG00000262152.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.016295419 |
Resistant |
| ENSG00000262362.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.015071205 |
Resistant |
| ENSG00000263931.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.022029147 |
Resistant |
| ENSG00000264107.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.014269097 |
Resistant |
| ENSG00000265055.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.038295332 |
Resistant |
| ENSG00000266411.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.020474719 |
Resistant |
| ENSG00000266900.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.048744054 |
Resistant |
| ENSG00000266921.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.040488157 |
Resistant |
| ENSG00000267018.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.008917292 |
Resistant |
| ENSG00000267082.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.046601341 |
Resistant |
| ENSG00000267159.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.012670498 |
Resistant |
| ENSG00000267221.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.033554018 |
Resistant |
| ENSG00000267262.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.023790083 |
Resistant |
| ENSG00000267764.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.030928046 |
Resistant |
| ENSG00000267804.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.01515279 |
Resistant |
| ENSG00000268047.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.048401581 |
Resistant |
| ENSG00000268095.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.035557989 |
Resistant |
| ENSG00000268970.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.012026359 |
Resistant |
| ENSG00000269066.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.024708648 |
Resistant |
| ENSG00000269444.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.018254001 |
Resistant |
| ENSG00000269956.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.048925323 |
Resistant |
| ENSG00000269959.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.000383382 |
Resistant |
| ENSG00000270168.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.00061681 |
Resistant |
| ENSG00000271020.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.046780058 |
Resistant |
| ENSG00000271643.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.021652035 |
Resistant |
| ENSG00000272030.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.02868377 |
Resistant |
| ENSG00000272068.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.039063607 |
Resistant |
| ENSG00000272079.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.002914749 |
Resistant |
| ENSG00000272482.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.024156758 |
Resistant |
| ENSG00000273289.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.038898569 |
Resistant |
| ENSG00000177133.6 |
Methotrexate |
Brain lower grade glioma |
0.001935108 |
Resistant |
| ENSG00000223759.2 |
Methotrexate |
Brain lower grade glioma |
0.000703445 |
Resistant |
| ENSG00000223804.1 |
Methotrexate |
Brain lower grade glioma |
0.040652758 |
Resistant |
| ENSG00000223811.1 |
Methotrexate |
Brain lower grade glioma |
0.005142883 |
Resistant |
| ENSG00000224821.5 |
Methotrexate |
Brain lower grade glioma |
0.039736949 |
Resistant |
| ENSG00000226335.2 |
Methotrexate |
Brain lower grade glioma |
0.033018783 |
Resistant |
| ENSG00000227733.4 |
Methotrexate |
Brain lower grade glioma |
0.027734265 |
Resistant |
| ENSG00000228495.1 |
Methotrexate |
Brain lower grade glioma |
0.032111326 |
Resistant |
| ENSG00000228857.2 |
Methotrexate |
Brain lower grade glioma |
0.002587836 |
Resistant |
| ENSG00000229739.1 |
Methotrexate |
Brain lower grade glioma |
0.000513613 |
Resistant |
| ENSG00000231551.2 |
Methotrexate |
Brain lower grade glioma |
0.000105292 |
Resistant |
| ENSG00000231734.4 |
Methotrexate |
Brain lower grade glioma |
0.001881806 |
Resistant |
| ENSG00000232290.1 |
Methotrexate |
Brain lower grade glioma |
0.022424799 |
Resistant |
| ENSG00000233368.2 |
Methotrexate |
Brain lower grade glioma |
0.026141107 |
Resistant |
| ENSG00000234520.1 |
Methotrexate |
Brain lower grade glioma |
0.04444484 |
Resistant |
| ENSG00000235770.1 |
Methotrexate |
Brain lower grade glioma |
0.03952575 |
Resistant |
| ENSG00000235999.1 |
Methotrexate |
Brain lower grade glioma |
0.026619863 |
Resistant |
| ENSG00000236740.2 |
Methotrexate |
Brain lower grade glioma |
0.0000157 |
Resistant |
| ENSG00000237181.1 |
Methotrexate |
Brain lower grade glioma |
0.014956646 |
Resistant |
| ENSG00000239828.2 |
Methotrexate |
Brain lower grade glioma |
0.017805831 |
Resistant |
| ENSG00000244063.1 |
Methotrexate |
Brain lower grade glioma |
0.038806898 |
Resistant |
| ENSG00000248724.2 |
Methotrexate |
Brain lower grade glioma |
0.00405212 |
Resistant |
| ENSG00000249035.2 |
Methotrexate |
Brain lower grade glioma |
0.032819106 |
Resistant |
| ENSG00000250075.1 |
Methotrexate |
Brain lower grade glioma |
0.003814124 |
Resistant |
| ENSG00000250237.1 |
Methotrexate |
Brain lower grade glioma |
0.012971022 |
Resistant |
| ENSG00000250250.1 |
Methotrexate |
Brain lower grade glioma |
0.049827918 |
Resistant |
| ENSG00000253355.1 |
Methotrexate |
Brain lower grade glioma |
0.004403317 |
Resistant |
| ENSG00000253955.1 |
Methotrexate |
Brain lower grade glioma |
0.029349575 |
Resistant |
| ENSG00000254350.1 |
Methotrexate |
Brain lower grade glioma |
0.027539336 |
Resistant |
| ENSG00000254960.2 |
Methotrexate |
Brain lower grade glioma |
0.036082269 |
Resistant |
| ENSG00000254981.1 |
Methotrexate |
Brain lower grade glioma |
0.005053813 |
Resistant |
| ENSG00000255565.1 |
Methotrexate |
Brain lower grade glioma |
0.047347615 |
Resistant |
| ENSG00000258558.1 |
Methotrexate |
Brain lower grade glioma |
0.031758464 |
Resistant |
| ENSG00000258858.1 |
Methotrexate |
Brain lower grade glioma |
0.007901235 |
Resistant |
| ENSG00000260008.1 |
Methotrexate |
Brain lower grade glioma |
0.00150333 |
Resistant |
| ENSG00000261039.1 |
Methotrexate |
Brain lower grade glioma |
0.034590908 |
Resistant |
| ENSG00000261040.2 |
Methotrexate |
Brain lower grade glioma |
0.044102434 |
Resistant |
| ENSG00000261451.1 |
Methotrexate |
Brain lower grade glioma |
0.044744634 |
Resistant |
| ENSG00000267416.1 |
Methotrexate |
Brain lower grade glioma |
0.045893975 |
Resistant |
| ENSG00000267446.1 |
Methotrexate |
Brain lower grade glioma |
0.033883312 |
Resistant |
| ENSG00000270022.2 |
Methotrexate |
Brain lower grade glioma |
0.013178083 |
Resistant |
| ENSG00000271631.1 |
Methotrexate |
Brain lower grade glioma |
0.031209243 |
Resistant |
| ENSG00000271897.1 |
Methotrexate |
Brain lower grade glioma |
0.035891364 |
Resistant |
| ENSG00000272144.1 |
Methotrexate |
Brain lower grade glioma |
0.045422092 |
Resistant |
| ENSG00000272235.1 |
Methotrexate |
Brain lower grade glioma |
0.031600815 |
Resistant |
| ENSG00000272789.1 |
Methotrexate |
Brain lower grade glioma |
0.010864055 |
Resistant |
| ENSG00000272825.1 |
Methotrexate |
Brain lower grade glioma |
0.020781712 |
Resistant |
| ENSG00000206337.6 |
Methotrexate |
Liver hepatocellular carcinoma |
0.030285486 |
Resistant |
| ENSG00000227963.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.031913362 |
Resistant |
| ENSG00000231760.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.039958457 |
Resistant |
| ENSG00000231890.3 |
Methotrexate |
Liver hepatocellular carcinoma |
0.00173734 |
Resistant |
| ENSG00000234584.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.039250075 |
Resistant |
| ENSG00000235398.4 |
Methotrexate |
Liver hepatocellular carcinoma |
0.019840619 |
Resistant |
| ENSG00000237499.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.030423053 |
Resistant |
| ENSG00000241769.3 |
Methotrexate |
Liver hepatocellular carcinoma |
0.031056889 |
Resistant |
| ENSG00000246422.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.047013893 |
Resistant |
| ENSG00000248254.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.026222878 |
Resistant |
| ENSG00000249249.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.038651639 |
Resistant |
| ENSG00000251221.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.023704585 |
Resistant |
| ENSG00000251361.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.0000745 |
Resistant |
| ENSG00000255867.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.019392263 |
Resistant |
| ENSG00000260060.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.038777357 |
Resistant |
| ENSG00000260352.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.016370966 |
Resistant |
| ENSG00000261737.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.048880715 |
Resistant |
| ENSG00000261840.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.02454514 |
Resistant |
| ENSG00000266397.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.035517151 |
Resistant |
| ENSG00000270426.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.035362636 |
Resistant |
| ENSG00000271127.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.018669387 |
Resistant |
| ENSG00000272669.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.012242515 |
Resistant |
| ENSG00000272870.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.021418479 |
Resistant |
| ENSG00000273131.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.03932184 |
Resistant |
| ENSG00000273143.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.011703076 |
Resistant |
| ENSG00000146666.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.045952372 |
Resistant |
| ENSG00000167117.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.046869298 |
Resistant |
| ENSG00000171889.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.025184385 |
Resistant |
| ENSG00000174680.5 |
Methotrexate |
Lung squamous cell carcinoma |
0.035400176 |
Resistant |
| ENSG00000177406.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.013424001 |
Resistant |
| ENSG00000178803.6 |
Methotrexate |
Lung squamous cell carcinoma |
0.015852516 |
Resistant |
| ENSG00000185168.5 |
Methotrexate |
Lung squamous cell carcinoma |
0.039831749 |
Resistant |
| ENSG00000185186.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.033789937 |
Resistant |
| ENSG00000189223.9 |
Methotrexate |
Lung squamous cell carcinoma |
0.019334177 |
Resistant |
| ENSG00000203280.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.019911479 |
Resistant |
| ENSG00000203886.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.03333778 |
Resistant |
| ENSG00000204055.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.010129967 |
Resistant |
| ENSG00000205056.8 |
Methotrexate |
Lung squamous cell carcinoma |
0.035975194 |
Resistant |
| ENSG00000205488.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.013317162 |
Resistant |
| ENSG00000205622.5 |
Methotrexate |
Lung squamous cell carcinoma |
0.042817372 |
Resistant |
| ENSG00000215244.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.007925981 |
Resistant |
| ENSG00000215483.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.027961035 |
Resistant |
| ENSG00000215769.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.032171182 |
Resistant |
| ENSG00000215841.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.024482989 |
Resistant |
| ENSG00000223387.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.008849288 |
Resistant |
| ENSG00000223396.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.01020313 |
Resistant |
| ENSG00000223462.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.026692255 |
Resistant |
| ENSG00000223485.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.041026435 |
Resistant |
| ENSG00000223523.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.046749833 |
Resistant |
| ENSG00000223675.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.004491663 |
Resistant |
| ENSG00000223872.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.039135083 |
Resistant |
| ENSG00000223901.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.010834813 |
Resistant |
| ENSG00000223975.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.049338416 |
Resistant |
| ENSG00000224063.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.004358039 |
Resistant |
| ENSG00000224081.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.002107754 |
Resistant |
| ENSG00000224095.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.017920333 |
Resistant |
| ENSG00000224276.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.041310264 |
Resistant |
| ENSG00000224649.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.039157082 |
Resistant |
| ENSG00000224794.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.03740958 |
Resistant |
| ENSG00000224818.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.036626615 |
Resistant |
| ENSG00000224992.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.00671359 |
Resistant |
| ENSG00000225292.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.018982093 |
Resistant |
| ENSG00000225298.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.041947996 |
Resistant |
| ENSG00000225315.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.009771611 |
Resistant |
| ENSG00000225328.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.008997237 |
Resistant |
| ENSG00000225383.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.021449367 |
Resistant |
| ENSG00000225431.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.024437789 |
Resistant |
| ENSG00000225744.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.012259738 |
Resistant |
| ENSG00000225839.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.025611418 |
Resistant |
| ENSG00000225931.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.041140158 |
Resistant |
| ENSG00000225981.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.025441562 |
Resistant |
| ENSG00000226026.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.032088485 |
Resistant |
| ENSG00000226251.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.020618197 |
Resistant |
| ENSG00000226335.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.008482974 |
Resistant |
| ENSG00000226598.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.043632013 |
Resistant |
| ENSG00000226676.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.045344578 |
Resistant |
| ENSG00000227356.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.035034237 |
Resistant |
| ENSG00000227479.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.035449135 |
Resistant |
| ENSG00000227502.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.018789267 |
Resistant |
| ENSG00000227695.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.011232291 |
Resistant |
| ENSG00000227733.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.013181277 |
Resistant |
| ENSG00000228748.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.024213706 |
Resistant |
| ENSG00000228865.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.034896295 |
Resistant |
| ENSG00000229321.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.003385125 |
Resistant |
| ENSG00000229373.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.048894827 |
Resistant |
| ENSG00000229404.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.049704204 |
Resistant |
| ENSG00000229463.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.041781835 |
Resistant |
| ENSG00000229656.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.013875703 |
Resistant |
| ENSG00000229660.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.003508124 |
Resistant |
| ENSG00000229986.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.036581773 |
Resistant |
| ENSG00000230051.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.017374536 |
Resistant |
| ENSG00000230140.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.025466408 |
Resistant |
| ENSG00000230526.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.020838077 |
Resistant |
| ENSG00000230728.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.032741858 |
Resistant |
| ENSG00000230812.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.049569837 |
Resistant |
| ENSG00000230825.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.049364073 |
Resistant |
| ENSG00000231160.5 |
Methotrexate |
Lung squamous cell carcinoma |
0.049328424 |
Resistant |
| ENSG00000231170.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.039591533 |
Resistant |
| ENSG00000231187.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.02110043 |
Resistant |
| ENSG00000231483.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.03888309 |
Resistant |
| ENSG00000231691.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.027522612 |
Resistant |
| ENSG00000232480.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.042811528 |
Resistant |
| ENSG00000232504.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.040392536 |
Resistant |
| ENSG00000232536.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.002540415 |
Resistant |
| ENSG00000232719.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.014263802 |
Resistant |
| ENSG00000233387.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.042364025 |
Resistant |
| ENSG00000234111.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.015330232 |
Resistant |
| ENSG00000234210.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.003857054 |
Resistant |
| ENSG00000234690.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.042677527 |
Resistant |
| ENSG00000235565.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.01124332 |
Resistant |
| ENSG00000235663.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.007586752 |
Resistant |
| ENSG00000235781.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.007042272 |
Resistant |
| ENSG00000236242.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.02917854 |
Resistant |
| ENSG00000236434.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.026152809 |
Resistant |
| ENSG00000236494.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.017032711 |
Resistant |
| ENSG00000236740.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.031392147 |
Resistant |
| ENSG00000237423.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.048096863 |
Resistant |
| ENSG00000237520.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.002367526 |
Resistant |
| ENSG00000237523.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.007471046 |
Resistant |
| ENSG00000237714.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.048686387 |
Resistant |
| ENSG00000237773.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.011435874 |
Resistant |
| ENSG00000237805.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.041355154 |
Resistant |
| ENSG00000237813.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.005252205 |
Resistant |
| ENSG00000237851.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.043228301 |
Resistant |
| ENSG00000238005.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.001360957 |
Resistant |
| ENSG00000239828.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.048969931 |
Resistant |
| ENSG00000239920.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.014460554 |
Resistant |
| ENSG00000240006.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.015042029 |
Resistant |
| ENSG00000242578.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.0378953 |
Resistant |
| ENSG00000242781.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.032479542 |
Resistant |
| ENSG00000242828.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.043378398 |
Resistant |
| ENSG00000243243.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.01295461 |
Resistant |
| ENSG00000244128.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.024846295 |
Resistant |
| ENSG00000245275.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.003532661 |
Resistant |
| ENSG00000245662.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.048016307 |
Resistant |
| ENSG00000246211.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.043961667 |
Resistant |
| ENSG00000246640.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.021181751 |
Resistant |
| ENSG00000247809.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.022708275 |
Resistant |
| ENSG00000248538.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.033231686 |
Resistant |
| ENSG00000248844.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.029743797 |
Resistant |
| ENSG00000248994.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.045150623 |
Resistant |
| ENSG00000249094.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.023850785 |
Resistant |
| ENSG00000249267.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.041601224 |
Resistant |
| ENSG00000249378.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.025783007 |
Resistant |
| ENSG00000249409.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.049609298 |
Resistant |
| ENSG00000249647.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.044274078 |
Resistant |
| ENSG00000249734.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.028296948 |
Resistant |
| ENSG00000250596.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.035891797 |
Resistant |
| ENSG00000250608.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.047308644 |
Resistant |
| ENSG00000251169.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.004086433 |
Resistant |
| ENSG00000251273.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.007019093 |
Resistant |
| ENSG00000251391.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.00794184 |
Resistant |
| ENSG00000251432.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.022060642 |
Resistant |
| ENSG00000251584.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.026503795 |
Resistant |
| ENSG00000251675.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.029756136 |
Resistant |
| ENSG00000253125.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.017855103 |
Resistant |
| ENSG00000253263.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.016404712 |
Resistant |
| ENSG00000253671.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.028555134 |
Resistant |
| ENSG00000253701.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.028804669 |
Resistant |
| ENSG00000253736.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.00252292 |
Resistant |
| ENSG00000254119.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.02334449 |
Resistant |
| ENSG00000254153.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.019368324 |
Resistant |
| ENSG00000254154.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.030365933 |
Resistant |
| ENSG00000254164.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.017162225 |
Resistant |
| ENSG00000254286.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.015545102 |
Resistant |
| ENSG00000254333.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.034590669 |
Resistant |
| ENSG00000254526.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.029133293 |
Resistant |
| ENSG00000254606.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.025257623 |
Resistant |
| ENSG00000254670.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.012266492 |
Resistant |
| ENSG00000255092.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.002190282 |
Resistant |
| ENSG00000255250.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.037884728 |
Resistant |
| ENSG00000255322.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.037539753 |
Resistant |
| ENSG00000255400.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.046543316 |
Resistant |
| ENSG00000255478.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.03385896 |
Resistant |
| ENSG00000255521.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.032158213 |
Resistant |
| ENSG00000255847.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.027208938 |
Resistant |
| ENSG00000255959.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.012272611 |
Resistant |
| ENSG00000256248.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.030293917 |
Resistant |
| ENSG00000256947.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.044544694 |
Resistant |
| ENSG00000257038.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.032379118 |
Resistant |
| ENSG00000257183.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.049374713 |
Resistant |
| ENSG00000257488.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.039103264 |
Resistant |
| ENSG00000257612.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.03386866 |
Resistant |
| ENSG00000257702.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.020666832 |
Resistant |
| ENSG00000257771.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.045301756 |
Resistant |
| ENSG00000257829.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.040215191 |
Resistant |
| ENSG00000257831.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.024320324 |
Resistant |
| ENSG00000258081.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.022023443 |
Resistant |
| ENSG00000258102.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.02290699 |
Resistant |
| ENSG00000258404.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.044123516 |
Resistant |
| ENSG00000258451.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.029461275 |
Resistant |
| ENSG00000258498.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.025965243 |
Resistant |
| ENSG00000258667.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.049241409 |
Resistant |
| ENSG00000258689.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.036567823 |
Resistant |
| ENSG00000258860.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.037364873 |
Resistant |
| ENSG00000258919.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.035058416 |
Resistant |
| ENSG00000258929.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.030839368 |
Resistant |
| ENSG00000258955.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.048264175 |
Resistant |
| ENSG00000259005.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.044849012 |
Resistant |
| ENSG00000259038.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.034010963 |
Resistant |
| ENSG00000259062.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.030140859 |
Resistant |
| ENSG00000259215.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.024148263 |
Resistant |
| ENSG00000259647.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.046651109 |
Resistant |
| ENSG00000260118.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.014993774 |
Resistant |
| ENSG00000260310.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.024912091 |
Resistant |
| ENSG00000260378.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.0358962 |
Resistant |
| ENSG00000260593.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.048746384 |
Resistant |
| ENSG00000260633.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.020372055 |
Resistant |
| ENSG00000260704.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.016502445 |
Resistant |
| ENSG00000260798.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.04471363 |
Resistant |
| ENSG00000260929.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.009726647 |
Resistant |
| ENSG00000260962.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.026120959 |
Resistant |
| ENSG00000260963.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.023774094 |
Resistant |
| ENSG00000261468.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.025390089 |
Resistant |
| ENSG00000261488.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.04962435 |
Resistant |
| ENSG00000261644.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.016999433 |
Resistant |
| ENSG00000261690.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.016170566 |
Resistant |
| ENSG00000261765.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.018239656 |
Resistant |
| ENSG00000262332.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.044375294 |
Resistant |
| ENSG00000262370.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.007482967 |
Resistant |
| ENSG00000262558.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.048237675 |
Resistant |
| ENSG00000263033.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.009476943 |
Resistant |
| ENSG00000263745.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.044619724 |
Resistant |
| ENSG00000264968.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.047968637 |
Resistant |
| ENSG00000265519.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.026226288 |
Resistant |
| ENSG00000265692.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.043271273 |
Resistant |
| ENSG00000266664.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.036901648 |
Resistant |
| ENSG00000266835.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.023493347 |
Resistant |
| ENSG00000266877.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.02076958 |
Resistant |
| ENSG00000266903.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.022686133 |
Resistant |
| ENSG00000266923.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.035580512 |
Resistant |
| ENSG00000266970.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.006075672 |
Resistant |
| ENSG00000267015.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.033338546 |
Resistant |
| ENSG00000267112.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.015221854 |
Resistant |
| ENSG00000267174.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.015757094 |
Resistant |
| ENSG00000267288.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.012267902 |
Resistant |
| ENSG00000267311.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.011519875 |
Resistant |
| ENSG00000267344.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.023639791 |
Resistant |
| ENSG00000267462.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.038173789 |
Resistant |
| ENSG00000267499.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.012328791 |
Resistant |
| ENSG00000267519.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.035287131 |
Resistant |
| ENSG00000267737.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.015548752 |
Resistant |
| ENSG00000267745.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.04676402 |
Resistant |
| ENSG00000268355.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.041321867 |
Resistant |
| ENSG00000268913.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.0184154 |
Resistant |
| ENSG00000269392.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.005086952 |
Resistant |
| ENSG00000269899.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.040555302 |
Resistant |
| ENSG00000269983.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.015809038 |
Resistant |
| ENSG00000269989.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.042165989 |
Resistant |
| ENSG00000270000.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.003842713 |
Resistant |
| ENSG00000270210.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.017234171 |
Resistant |
| ENSG00000270302.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.022701555 |
Resistant |
| ENSG00000270883.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.018640825 |
Resistant |
| ENSG00000271344.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.001948871 |
Resistant |
| ENSG00000271788.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.006982322 |
Resistant |
| ENSG00000271983.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.01235276 |
Resistant |
| ENSG00000272144.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.001695372 |
Resistant |
| ENSG00000272221.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.041327288 |
Resistant |
| ENSG00000272382.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.00458734 |
Resistant |
| ENSG00000272465.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.034560813 |
Resistant |
| ENSG00000272564.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.033856804 |
Resistant |
| ENSG00000272597.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.047482227 |
Resistant |
| ENSG00000272659.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.024072506 |
Resistant |
| ENSG00000272668.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.042762881 |
Resistant |
| ENSG00000272861.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.007905955 |
Resistant |
| ENSG00000273012.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.03990171 |
Resistant |
| ENSG00000273065.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.022534641 |
Resistant |
| ENSG00000273129.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.04639216 |
Resistant |
| ENSG00000273174.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.003704033 |
Resistant |
| ENSG00000118412.8 |
Methotrexate |
Pancreatic adenocarcinoma |
0.027546365 |
Resistant |
| ENSG00000157306.10 |
Methotrexate |
Pancreatic adenocarcinoma |
0.043840062 |
Resistant |
| ENSG00000175701.6 |
Methotrexate |
Pancreatic adenocarcinoma |
0.004712573 |
Resistant |
| ENSG00000185837.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.040735731 |
Resistant |
| ENSG00000186615.6 |
Methotrexate |
Pancreatic adenocarcinoma |
0.030527601 |
Resistant |
| ENSG00000196559.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.001617609 |
Resistant |
| ENSG00000203801.4 |
Methotrexate |
Pancreatic adenocarcinoma |
0.019139432 |
Resistant |
| ENSG00000205559.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.045932796 |
Resistant |
| ENSG00000213971.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.015103646 |
Resistant |
| ENSG00000214770.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.040330846 |
Resistant |
| ENSG00000214783.5 |
Methotrexate |
Pancreatic adenocarcinoma |
0.017830348 |
Resistant |
| ENSG00000215374.5 |
Methotrexate |
Pancreatic adenocarcinoma |
0.034468947 |
Resistant |
| ENSG00000223461.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.020716317 |
Resistant |
| ENSG00000223552.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.043031253 |
Resistant |
| ENSG00000224116.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.019789937 |
Resistant |
| ENSG00000224209.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.030888272 |
Resistant |
| ENSG00000224429.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.011611599 |
Resistant |
| ENSG00000224950.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.037384293 |
Resistant |
| ENSG00000225300.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.04990827 |
Resistant |
| ENSG00000225725.4 |
Methotrexate |
Pancreatic adenocarcinoma |
0.017314428 |
Resistant |
| ENSG00000225744.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.00206363 |
Resistant |
| ENSG00000226419.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.045833121 |
Resistant |
| ENSG00000227210.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.026036744 |
Resistant |
| ENSG00000227237.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.03536657 |
Resistant |
| ENSG00000227245.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.004295216 |
Resistant |
| ENSG00000227398.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.038529033 |
Resistant |
| ENSG00000227403.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.026607552 |
Resistant |
| ENSG00000227479.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.009912908 |
Resistant |
| ENSG00000227888.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.036166474 |
Resistant |
| ENSG00000228701.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.040741544 |
Resistant |
| ENSG00000228956.4 |
Methotrexate |
Pancreatic adenocarcinoma |
0.037303023 |
Resistant |
| ENSG00000229152.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.024133841 |
Resistant |
| ENSG00000229591.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.039859981 |
Resistant |
| ENSG00000230074.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.022320064 |
Resistant |
| ENSG00000230082.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.022690327 |
Resistant |
| ENSG00000230427.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.047518958 |
Resistant |
| ENSG00000231663.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.043243299 |
Resistant |
| ENSG00000231704.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.031425914 |
Resistant |
| ENSG00000231851.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.039940001 |
Resistant |
| ENSG00000232065.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.002517739 |
Resistant |
| ENSG00000232098.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.029857482 |
Resistant |
| ENSG00000232442.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.01749972 |
Resistant |
| ENSG00000232611.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.046490558 |
Resistant |
| ENSG00000232956.4 |
Methotrexate |
Pancreatic adenocarcinoma |
0.01046831 |
Resistant |
| ENSG00000233033.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.025946495 |
Resistant |
| ENSG00000233330.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.011196442 |
Resistant |
| ENSG00000233593.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.024318771 |
Resistant |
| ENSG00000233757.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.048778928 |
Resistant |
| ENSG00000233937.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.034949064 |
Resistant |
| ENSG00000234225.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.015060159 |
Resistant |
| ENSG00000235586.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.009644764 |
Resistant |
| ENSG00000235919.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.034324297 |
Resistant |
| ENSG00000236098.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.002772608 |
Resistant |
| ENSG00000236200.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.009457948 |
Resistant |
| ENSG00000236498.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.005926587 |
Resistant |
| ENSG00000236519.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.048870139 |
Resistant |
| ENSG00000236869.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.002199128 |
Resistant |
| ENSG00000236908.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.038525068 |
Resistant |
| ENSG00000237886.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.028899832 |
Resistant |
| ENSG00000237950.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.030941606 |
Resistant |
| ENSG00000238133.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.026119969 |
Resistant |
| ENSG00000238186.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.023187215 |
Resistant |
| ENSG00000238198.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.012869823 |
Resistant |
| ENSG00000238287.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.047683431 |
Resistant |
| ENSG00000239569.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.031458955 |
Resistant |
| ENSG00000240449.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.026870427 |
Resistant |
| ENSG00000242104.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.004273112 |
Resistant |
| ENSG00000245526.4 |
Methotrexate |
Pancreatic adenocarcinoma |
0.025125482 |
Resistant |
| ENSG00000245904.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.022639834 |
Resistant |
| ENSG00000246640.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.014713717 |
Resistant |
| ENSG00000247400.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.015440889 |
Resistant |
| ENSG00000248367.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.025230634 |
Resistant |
| ENSG00000248668.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.007569618 |
Resistant |
| ENSG00000249859.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.038175039 |
Resistant |
| ENSG00000250012.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.007542656 |
Resistant |
| ENSG00000250365.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.032892099 |
Resistant |
| ENSG00000250999.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.011024336 |
Resistant |
| ENSG00000251556.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.015362431 |
Resistant |
| ENSG00000253741.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.018493058 |
Resistant |
| ENSG00000253848.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.024500444 |
Resistant |
| ENSG00000253948.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.036893071 |
Resistant |
| ENSG00000254295.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.046748592 |
Resistant |
| ENSG00000255164.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.025521107 |
Resistant |
| ENSG00000255247.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.044676231 |
Resistant |
| ENSG00000255867.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.026470972 |
Resistant |
| ENSG00000257894.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.034108948 |
Resistant |
| ENSG00000258825.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.012073437 |
Resistant |
| ENSG00000258851.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.028162819 |
Resistant |
| ENSG00000259804.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.022231243 |
Resistant |
| ENSG00000259943.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.043968387 |
Resistant |
| ENSG00000260017.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.028626645 |
Resistant |
| ENSG00000260018.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.041003579 |
Resistant |
| ENSG00000260021.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.031750116 |
Resistant |
| ENSG00000260236.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.04876016 |
Resistant |
| ENSG00000260448.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.031199224 |
Resistant |
| ENSG00000260648.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.015986592 |
Resistant |
| ENSG00000260927.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.026597141 |
Resistant |
| ENSG00000261204.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.045418071 |
Resistant |
| ENSG00000261431.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.004827005 |
Resistant |
| ENSG00000261801.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.016055535 |
Resistant |
| ENSG00000262228.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.039430936 |
Resistant |
| ENSG00000262879.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.049514011 |
Resistant |
| ENSG00000263120.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.021219258 |
Resistant |
| ENSG00000263470.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.046833214 |
Resistant |
| ENSG00000264575.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.038558682 |
Resistant |
| ENSG00000265091.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.016278364 |
Resistant |
| ENSG00000266340.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.033836325 |
Resistant |
| ENSG00000266601.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.049676813 |
Resistant |
| ENSG00000266717.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.022362717 |
Resistant |
| ENSG00000266801.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.025756808 |
Resistant |
| ENSG00000266821.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.02517996 |
Resistant |
| ENSG00000266983.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.027065098 |
Resistant |
| ENSG00000267067.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.029786532 |
Resistant |
| ENSG00000267232.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.038454505 |
Resistant |
| ENSG00000267248.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.012726979 |
Resistant |
| ENSG00000267475.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.034044062 |
Resistant |
| ENSG00000267476.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.012051221 |
Resistant |
| ENSG00000267510.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.030079349 |
Resistant |
| ENSG00000267567.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.016975744 |
Resistant |
| ENSG00000267666.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.044206621 |
Resistant |
| ENSG00000267858.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.011002674 |
Resistant |
| ENSG00000267934.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.034111826 |
Resistant |
| ENSG00000268015.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.038977846 |
Resistant |
| ENSG00000268049.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.017147199 |
Resistant |
| ENSG00000268392.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.030763425 |
Resistant |
| ENSG00000268543.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.049958076 |
Resistant |
| ENSG00000268583.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.00648997 |
Resistant |
| ENSG00000268683.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.034197291 |
Resistant |
| ENSG00000268945.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.043101583 |
Resistant |
| ENSG00000269038.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.018235885 |
Resistant |
| ENSG00000269107.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.002276799 |
Resistant |
| ENSG00000269416.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.044322504 |
Resistant |
| ENSG00000269439.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.039382863 |
Resistant |
| ENSG00000269444.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.014732026 |
Resistant |
| ENSG00000269486.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.034733185 |
Resistant |
| ENSG00000269867.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.011773129 |
Resistant |
| ENSG00000269980.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.006765989 |
Resistant |
| ENSG00000270006.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.040543346 |
Resistant |
| ENSG00000270074.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.035818819 |
Resistant |
| ENSG00000270141.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.028811223 |
Resistant |
| ENSG00000270145.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.046095728 |
Resistant |
| ENSG00000270170.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.007137228 |
Resistant |
| ENSG00000271643.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.040726118 |
Resistant |
| ENSG00000271788.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.047185648 |
Resistant |
| ENSG00000272092.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.037403334 |
Resistant |
| ENSG00000272524.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.006036404 |
Resistant |
| ENSG00000272667.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.026393345 |
Resistant |
| ENSG00000272788.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.043656386 |
Resistant |
| ENSG00000272892.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.02544869 |
Resistant |
| ENSG00000273015.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.020113367 |
Resistant |
| ENSG00000273091.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.006898822 |
Resistant |
| ENSG00000273367.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.047541111 |
Resistant |
| ENSG00000273432.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.036949764 |
Resistant |
| ENSG00000223653.1 |
Methotrexate |
Sarcoma |
0.047271439 |
Resistant |
| ENSG00000224821.5 |
Methotrexate |
Sarcoma |
0.040874259 |
Resistant |
| ENSG00000225938.1 |
Methotrexate |
Sarcoma |
0.028301598 |
Resistant |
| ENSG00000226167.1 |
Methotrexate |
Sarcoma |
0.049541653 |
Resistant |
| ENSG00000227258.1 |
Methotrexate |
Sarcoma |
0.016839483 |
Resistant |
| ENSG00000229656.2 |
Methotrexate |
Sarcoma |
0.049210499 |
Resistant |
| ENSG00000229771.1 |
Methotrexate |
Sarcoma |
0.013327691 |
Resistant |
| ENSG00000231407.1 |
Methotrexate |
Sarcoma |
0.010512087 |
Resistant |
| ENSG00000231713.2 |
Methotrexate |
Sarcoma |
0.000626239 |
Resistant |
| ENSG00000232453.1 |
Methotrexate |
Sarcoma |
0.013906082 |
Resistant |
| ENSG00000233069.1 |
Methotrexate |
Sarcoma |
0.045735244 |
Resistant |
| ENSG00000233237.2 |
Methotrexate |
Sarcoma |
0.037307712 |
Resistant |
| ENSG00000233330.1 |
Methotrexate |
Sarcoma |
0.040665833 |
Resistant |
| ENSG00000233452.2 |
Methotrexate |
Sarcoma |
0.013446608 |
Resistant |
| ENSG00000234520.1 |
Methotrexate |
Sarcoma |
0.006153157 |
Resistant |
| ENSG00000236936.1 |
Methotrexate |
Sarcoma |
0.015671982 |
Resistant |
| ENSG00000237499.2 |
Methotrexate |
Sarcoma |
0.004518884 |
Resistant |
| ENSG00000246130.1 |
Methotrexate |
Sarcoma |
0.038488156 |
Resistant |
| ENSG00000246331.2 |
Methotrexate |
Sarcoma |
0.049012345 |
Resistant |
| ENSG00000248360.3 |
Methotrexate |
Sarcoma |
0.049143728 |
Resistant |
| ENSG00000249328.2 |
Methotrexate |
Sarcoma |
0.0000712 |
Resistant |
| ENSG00000251580.1 |
Methotrexate |
Sarcoma |
0.033258603 |
Resistant |
| ENSG00000253172.1 |
Methotrexate |
Sarcoma |
0.021166194 |
Resistant |
| ENSG00000254418.1 |
Methotrexate |
Sarcoma |
0.035803552 |
Resistant |
| ENSG00000254703.2 |
Methotrexate |
Sarcoma |
0.02927721 |
Resistant |
| ENSG00000255186.1 |
Methotrexate |
Sarcoma |
0.028701653 |
Resistant |
| ENSG00000258082.1 |
Methotrexate |
Sarcoma |
0.033011394 |
Resistant |
| ENSG00000259287.1 |
Methotrexate |
Sarcoma |
0.016200954 |
Resistant |
| ENSG00000261103.1 |
Methotrexate |
Sarcoma |
0.037514695 |
Resistant |
| ENSG00000261737.1 |
Methotrexate |
Sarcoma |
0.009481633 |
Resistant |
| ENSG00000262810.1 |
Methotrexate |
Sarcoma |
0.029596181 |
Resistant |
| ENSG00000262905.1 |
Methotrexate |
Sarcoma |
0.045327392 |
Resistant |
| ENSG00000263466.1 |
Methotrexate |
Sarcoma |
0.002266229 |
Resistant |
| ENSG00000264107.1 |
Methotrexate |
Sarcoma |
0.045526545 |
Resistant |
| ENSG00000266289.1 |
Methotrexate |
Sarcoma |
0.021269779 |
Resistant |
| ENSG00000266378.1 |
Methotrexate |
Sarcoma |
0.022970801 |
Resistant |
| ENSG00000267316.1 |
Methotrexate |
Sarcoma |
0.030616796 |
Resistant |
| ENSG00000267504.1 |
Methotrexate |
Sarcoma |
0.028570081 |
Resistant |
| ENSG00000269966.1 |
Methotrexate |
Sarcoma |
0.028654906 |
Resistant |
| ENSG00000270949.1 |
Methotrexate |
Sarcoma |
0.000650497 |
Resistant |
| ENSG00000271324.1 |
Methotrexate |
Sarcoma |
0.021891259 |
Resistant |
| ENSG00000271734.1 |
Methotrexate |
Sarcoma |
0.015190799 |
Resistant |
| ENSG00000271874.1 |
Methotrexate |
Sarcoma |
0.049639659 |
Resistant |
| ENSG00000271996.1 |
Methotrexate |
Sarcoma |
0.009328592 |
Resistant |
| ENSG00000272754.1 |
Methotrexate |
Sarcoma |
0.033405366 |
Resistant |
| ENSG00000272933.1 |
Methotrexate |
Sarcoma |
0.017885139 |
Resistant |
| ENSG00000273368.1 |
Methotrexate |
Sarcoma |
0.029644054 |
Resistant |
| ENSG00000203279.3 |
Methotrexate |
Skin cutaneous melanoma |
0.045984885 |
Resistant |
| ENSG00000214432.5 |
Methotrexate |
Skin cutaneous melanoma |
0.045215991 |
Resistant |
| ENSG00000224698.1 |
Methotrexate |
Skin cutaneous melanoma |
0.000619727 |
Resistant |
| ENSG00000224764.1 |
Methotrexate |
Skin cutaneous melanoma |
0.045624522 |
Resistant |
| ENSG00000226367.1 |
Methotrexate |
Skin cutaneous melanoma |
0.023622848 |
Resistant |
| ENSG00000227946.1 |
Methotrexate |
Skin cutaneous melanoma |
0.033700098 |
Resistant |
| ENSG00000228386.2 |
Methotrexate |
Skin cutaneous melanoma |
0.029515541 |
Resistant |
| ENSG00000228412.2 |
Methotrexate |
Skin cutaneous melanoma |
0.00511648 |
Resistant |
| ENSG00000228481.1 |
Methotrexate |
Skin cutaneous melanoma |
0.031244359 |
Resistant |
| ENSG00000228794.4 |
Methotrexate |
Skin cutaneous melanoma |
0.045541316 |
Resistant |
| ENSG00000229980.4 |
Methotrexate |
Skin cutaneous melanoma |
0.029276294 |
Resistant |
| ENSG00000230054.1 |
Methotrexate |
Skin cutaneous melanoma |
0.018210228 |
Resistant |
| ENSG00000231439.3 |
Methotrexate |
Skin cutaneous melanoma |
0.021447335 |
Resistant |
| ENSG00000231636.1 |
Methotrexate |
Skin cutaneous melanoma |
0.00534522 |
Resistant |
| ENSG00000232034.1 |
Methotrexate |
Skin cutaneous melanoma |
0.020568623 |
Resistant |
| ENSG00000232455.2 |
Methotrexate |
Skin cutaneous melanoma |
0.010944793 |
Resistant |
| ENSG00000235852.1 |
Methotrexate |
Skin cutaneous melanoma |
0.041425216 |
Resistant |
| ENSG00000237017.1 |
Methotrexate |
Skin cutaneous melanoma |
0.032300102 |
Resistant |
| ENSG00000237529.1 |
Methotrexate |
Skin cutaneous melanoma |
0.048540925 |
Resistant |
| ENSG00000238122.1 |
Methotrexate |
Skin cutaneous melanoma |
0.000583822 |
Resistant |
| ENSG00000239335.4 |
Methotrexate |
Skin cutaneous melanoma |
0.023116144 |
Resistant |
| ENSG00000246422.2 |
Methotrexate |
Skin cutaneous melanoma |
0.020362287 |
Resistant |
| ENSG00000253400.1 |
Methotrexate |
Skin cutaneous melanoma |
0.049132927 |
Resistant |
| ENSG00000253878.1 |
Methotrexate |
Skin cutaneous melanoma |
0.006802326 |
Resistant |
| ENSG00000253917.3 |
Methotrexate |
Skin cutaneous melanoma |
0.042917101 |
Resistant |
| ENSG00000254207.1 |
Methotrexate |
Skin cutaneous melanoma |
0.018894871 |
Resistant |
| ENSG00000254208.1 |
Methotrexate |
Skin cutaneous melanoma |
0.038038219 |
Resistant |
| ENSG00000259687.1 |
Methotrexate |
Skin cutaneous melanoma |
0.015619084 |
Resistant |
| ENSG00000259884.1 |
Methotrexate |
Skin cutaneous melanoma |
0.032566122 |
Resistant |
| ENSG00000260086.1 |
Methotrexate |
Skin cutaneous melanoma |
0.049734014 |
Resistant |
| ENSG00000260411.2 |
Methotrexate |
Skin cutaneous melanoma |
0.032531102 |
Resistant |
| ENSG00000260805.1 |
Methotrexate |
Skin cutaneous melanoma |
0.03023774 |
Resistant |
| ENSG00000260932.1 |
Methotrexate |
Skin cutaneous melanoma |
0.002334199 |
Resistant |
| ENSG00000261341.1 |
Methotrexate |
Skin cutaneous melanoma |
0.04966823 |
Resistant |
| ENSG00000262001.1 |
Methotrexate |
Skin cutaneous melanoma |
0.016758869 |
Resistant |
| ENSG00000263400.2 |
Methotrexate |
Skin cutaneous melanoma |
0.037692649 |
Resistant |
| ENSG00000265399.1 |
Methotrexate |
Skin cutaneous melanoma |
0.019067788 |
Resistant |
| ENSG00000266402.2 |
Methotrexate |
Skin cutaneous melanoma |
0.009121675 |
Resistant |
| ENSG00000267347.1 |
Methotrexate |
Skin cutaneous melanoma |
0.012871779 |
Resistant |
| ENSG00000267898.1 |
Methotrexate |
Skin cutaneous melanoma |
0.005093845 |
Resistant |
| ENSG00000268605.1 |
Methotrexate |
Skin cutaneous melanoma |
0.028665927 |
Resistant |
| ENSG00000268655.1 |
Methotrexate |
Skin cutaneous melanoma |
0.029387783 |
Resistant |
| ENSG00000270068.1 |
Methotrexate |
Skin cutaneous melanoma |
0.017652019 |
Resistant |
| ENSG00000270173.1 |
Methotrexate |
Skin cutaneous melanoma |
0.042070302 |
Resistant |
| ENSG00000270964.1 |
Methotrexate |
Skin cutaneous melanoma |
0.03313787 |
Resistant |
| ENSG00000272236.1 |
Methotrexate |
Skin cutaneous melanoma |
0.031807547 |
Resistant |
| ENSG00000272688.1 |
Methotrexate |
Skin cutaneous melanoma |
0.013717228 |
Resistant |
| ENSG00000272716.1 |
Methotrexate |
Skin cutaneous melanoma |
0.004822176 |
Resistant |
| ENSG00000273176.1 |
Methotrexate |
Skin cutaneous melanoma |
0.024824048 |
Resistant |
| ENSG00000273456.1 |
Methotrexate |
Skin cutaneous melanoma |
0.048246296 |
Resistant |
| ENSG00000196421.3 |
Methotrexate |
Breast invasive carcinoma |
0.0448849 |
Sensitive |
| ENSG00000215692.2 |
Methotrexate |
Breast invasive carcinoma |
0.04723129 |
Sensitive |
| ENSG00000215841.3 |
Methotrexate |
Breast invasive carcinoma |
0.041261319 |
Sensitive |
| ENSG00000223907.1 |
Methotrexate |
Breast invasive carcinoma |
0.012616047 |
Sensitive |
| ENSG00000224660.1 |
Methotrexate |
Breast invasive carcinoma |
0.027785301 |
Sensitive |
| ENSG00000225408.1 |
Methotrexate |
Breast invasive carcinoma |
0.00398188 |
Sensitive |
| ENSG00000225527.1 |
Methotrexate |
Breast invasive carcinoma |
0.047557979 |
Sensitive |
| ENSG00000226332.2 |
Methotrexate |
Breast invasive carcinoma |
0.048961091 |
Sensitive |
| ENSG00000226453.1 |
Methotrexate |
Breast invasive carcinoma |
0.046264629 |
Sensitive |
| ENSG00000227885.1 |
Methotrexate |
Breast invasive carcinoma |
0.030376011 |
Sensitive |
| ENSG00000228554.1 |
Methotrexate |
Breast invasive carcinoma |
0.005527381 |
Sensitive |
| ENSG00000229869.1 |
Methotrexate |
Breast invasive carcinoma |
0.001900704 |
Sensitive |
| ENSG00000230124.2 |
Methotrexate |
Breast invasive carcinoma |
0.000224172 |
Sensitive |
| ENSG00000230724.5 |
Methotrexate |
Breast invasive carcinoma |
0.000366078 |
Sensitive |
| ENSG00000230825.1 |
Methotrexate |
Breast invasive carcinoma |
0.02639416 |
Sensitive |
| ENSG00000231336.1 |
Methotrexate |
Breast invasive carcinoma |
0.044803075 |
Sensitive |
| ENSG00000232586.1 |
Methotrexate |
Breast invasive carcinoma |
0.002127879 |
Sensitive |
| ENSG00000233013.4 |
Methotrexate |
Breast invasive carcinoma |
0.012222808 |
Sensitive |
| ENSG00000233030.2 |
Methotrexate |
Breast invasive carcinoma |
0.009068344 |
Sensitive |
| ENSG00000234393.1 |
Methotrexate |
Breast invasive carcinoma |
0.001925051 |
Sensitive |
| ENSG00000234571.1 |
Methotrexate |
Breast invasive carcinoma |
0.027443855 |
Sensitive |
| ENSG00000234818.1 |
Methotrexate |
Breast invasive carcinoma |
0.011886509 |
Sensitive |
| ENSG00000234869.1 |
Methotrexate |
Breast invasive carcinoma |
0.047496896 |
Sensitive |
| ENSG00000235373.1 |
Methotrexate |
Breast invasive carcinoma |
0.001519304 |
Sensitive |
| ENSG00000235522.2 |
Methotrexate |
Breast invasive carcinoma |
0.039228041 |
Sensitive |
| ENSG00000235834.1 |
Methotrexate |
Breast invasive carcinoma |
0.04859011 |
Sensitive |
| ENSG00000236438.2 |
Methotrexate |
Breast invasive carcinoma |
0.036048064 |
Sensitive |
| ENSG00000237073.1 |
Methotrexate |
Breast invasive carcinoma |
0.009742374 |
Sensitive |
| ENSG00000237094.7 |
Methotrexate |
Breast invasive carcinoma |
0.0000371 |
Sensitive |
| ENSG00000237594.2 |
Methotrexate |
Breast invasive carcinoma |
0.03743138 |
Sensitive |
| ENSG00000238035.4 |
Methotrexate |
Breast invasive carcinoma |
0.000579256 |
Sensitive |
| ENSG00000239906.1 |
Methotrexate |
Breast invasive carcinoma |
0.017153012 |
Sensitive |
| ENSG00000240618.1 |
Methotrexate |
Breast invasive carcinoma |
0.016111131 |
Sensitive |
| ENSG00000241599.1 |
Methotrexate |
Breast invasive carcinoma |
0.004627436 |
Sensitive |
| ENSG00000241860.2 |
Methotrexate |
Breast invasive carcinoma |
0.001642119 |
Sensitive |
| ENSG00000243368.2 |
Methotrexate |
Breast invasive carcinoma |
0.026465715 |
Sensitive |
| ENSG00000247345.2 |
Methotrexate |
Breast invasive carcinoma |
0.043733432 |
Sensitive |
| ENSG00000248517.1 |
Methotrexate |
Breast invasive carcinoma |
0.021639226 |
Sensitive |
| ENSG00000249417.1 |
Methotrexate |
Breast invasive carcinoma |
0.041461727 |
Sensitive |
| ENSG00000250295.2 |
Methotrexate |
Breast invasive carcinoma |
0.018971188 |
Sensitive |
| ENSG00000250404.1 |
Methotrexate |
Breast invasive carcinoma |
0.023728946 |
Sensitive |
| ENSG00000250764.1 |
Methotrexate |
Breast invasive carcinoma |
0.018011191 |
Sensitive |
| ENSG00000251580.1 |
Methotrexate |
Breast invasive carcinoma |
0.045276651 |
Sensitive |
| ENSG00000253372.1 |
Methotrexate |
Breast invasive carcinoma |
0.011571549 |
Sensitive |
| ENSG00000254676.1 |
Methotrexate |
Breast invasive carcinoma |
0.010966747 |
Sensitive |
| ENSG00000255050.1 |
Methotrexate |
Breast invasive carcinoma |
0.01155438 |
Sensitive |
| ENSG00000255081.1 |
Methotrexate |
Breast invasive carcinoma |
0.025496145 |
Sensitive |
| ENSG00000255229.1 |
Methotrexate |
Breast invasive carcinoma |
0.005621157 |
Sensitive |
| ENSG00000255893.1 |
Methotrexate |
Breast invasive carcinoma |
0.011758533 |
Sensitive |
| ENSG00000255946.1 |
Methotrexate |
Breast invasive carcinoma |
0.021575373 |
Sensitive |
| ENSG00000257084.1 |
Methotrexate |
Breast invasive carcinoma |
0.047996535 |
Sensitive |
| ENSG00000257366.1 |
Methotrexate |
Breast invasive carcinoma |
0.049284247 |
Sensitive |
| ENSG00000257391.1 |
Methotrexate |
Breast invasive carcinoma |
0.047401639 |
Sensitive |
| ENSG00000257563.1 |
Methotrexate |
Breast invasive carcinoma |
0.024023756 |
Sensitive |
| ENSG00000257808.1 |
Methotrexate |
Breast invasive carcinoma |
0.014491572 |
Sensitive |
| ENSG00000258354.1 |
Methotrexate |
Breast invasive carcinoma |
0.032442296 |
Sensitive |
| ENSG00000259116.1 |
Methotrexate |
Breast invasive carcinoma |
0.026400664 |
Sensitive |
| ENSG00000259563.1 |
Methotrexate |
Breast invasive carcinoma |
0.019250844 |
Sensitive |
| ENSG00000259702.1 |
Methotrexate |
Breast invasive carcinoma |
0.0469852 |
Sensitive |
| ENSG00000259826.1 |
Methotrexate |
Breast invasive carcinoma |
0.017374683 |
Sensitive |
| ENSG00000259840.1 |
Methotrexate |
Breast invasive carcinoma |
0.014615369 |
Sensitive |
| ENSG00000260261.1 |
Methotrexate |
Breast invasive carcinoma |
0.003144485 |
Sensitive |
| ENSG00000260360.1 |
Methotrexate |
Breast invasive carcinoma |
0.024222305 |
Sensitive |
| ENSG00000260430.1 |
Methotrexate |
Breast invasive carcinoma |
0.017174476 |
Sensitive |
| ENSG00000260468.1 |
Methotrexate |
Breast invasive carcinoma |
0.000251772 |
Sensitive |
| ENSG00000260528.2 |
Methotrexate |
Breast invasive carcinoma |
0.008724562 |
Sensitive |
| ENSG00000260671.1 |
Methotrexate |
Breast invasive carcinoma |
0.012492681 |
Sensitive |
| ENSG00000261172.1 |
Methotrexate |
Breast invasive carcinoma |
0.01359765 |
Sensitive |
| ENSG00000261386.2 |
Methotrexate |
Breast invasive carcinoma |
0.011287952 |
Sensitive |
| ENSG00000261399.1 |
Methotrexate |
Breast invasive carcinoma |
0.001160832 |
Sensitive |
| ENSG00000261716.1 |
Methotrexate |
Breast invasive carcinoma |
0.00157821 |
Sensitive |
| ENSG00000265334.1 |
Methotrexate |
Breast invasive carcinoma |
0.000885111 |
Sensitive |
| ENSG00000265490.1 |
Methotrexate |
Breast invasive carcinoma |
0.016175142 |
Sensitive |
| ENSG00000265908.1 |
Methotrexate |
Breast invasive carcinoma |
0.010010944 |
Sensitive |
| ENSG00000266578.1 |
Methotrexate |
Breast invasive carcinoma |
0.045153828 |
Sensitive |
| ENSG00000268204.1 |
Methotrexate |
Breast invasive carcinoma |
0.019244887 |
Sensitive |
| ENSG00000268520.1 |
Methotrexate |
Breast invasive carcinoma |
0.026637401 |
Sensitive |
| ENSG00000269489.1 |
Methotrexate |
Breast invasive carcinoma |
0.019488407 |
Sensitive |
| ENSG00000270157.1 |
Methotrexate |
Breast invasive carcinoma |
0.039777305 |
Sensitive |
| ENSG00000271218.1 |
Methotrexate |
Breast invasive carcinoma |
0.000492929 |
Sensitive |
| ENSG00000271849.1 |
Methotrexate |
Breast invasive carcinoma |
0.004560828 |
Sensitive |
| ENSG00000272079.1 |
Methotrexate |
Breast invasive carcinoma |
0.022488553 |
Sensitive |
| ENSG00000272086.1 |
Methotrexate |
Breast invasive carcinoma |
0.035256219 |
Sensitive |
| ENSG00000272716.1 |
Methotrexate |
Breast invasive carcinoma |
0.025181824 |
Sensitive |
| ENSG00000272732.1 |
Methotrexate |
Breast invasive carcinoma |
0.009428739 |
Sensitive |
| ENSG00000272792.1 |
Methotrexate |
Breast invasive carcinoma |
0.027591136 |
Sensitive |
| ENSG00000272894.1 |
Methotrexate |
Breast invasive carcinoma |
0.018047243 |
Sensitive |
| ENSG00000272953.1 |
Methotrexate |
Breast invasive carcinoma |
0.030942202 |
Sensitive |
| ENSG00000272993.1 |
Methotrexate |
Breast invasive carcinoma |
0.000479279 |
Sensitive |
| ENSG00000273071.1 |
Methotrexate |
Breast invasive carcinoma |
0.005528653 |
Sensitive |
| ENSG00000273308.1 |
Methotrexate |
Breast invasive carcinoma |
0.005534203 |
Sensitive |
| ENSG00000214145.2 |
Methotrexate |
Colon adenocarcinoma |
0.033451194 |
Sensitive |
| ENSG00000214691.6 |
Methotrexate |
Colon adenocarcinoma |
0.003551452 |
Sensitive |
| ENSG00000221817.5 |
Methotrexate |
Colon adenocarcinoma |
0.01783769 |
Sensitive |
| ENSG00000223571.1 |
Methotrexate |
Colon adenocarcinoma |
0.007491931 |
Sensitive |
| ENSG00000223764.2 |
Methotrexate |
Colon adenocarcinoma |
0.041888935 |
Sensitive |
| ENSG00000224356.3 |
Methotrexate |
Colon adenocarcinoma |
0.028091829 |
Sensitive |
| ENSG00000225173.1 |
Methotrexate |
Colon adenocarcinoma |
0.007314367 |
Sensitive |
| ENSG00000225285.1 |
Methotrexate |
Colon adenocarcinoma |
0.002952458 |
Sensitive |
| ENSG00000225548.1 |
Methotrexate |
Colon adenocarcinoma |
0.021204179 |
Sensitive |
| ENSG00000226862.1 |
Methotrexate |
Colon adenocarcinoma |
0.022556396 |
Sensitive |
| ENSG00000229970.3 |
Methotrexate |
Colon adenocarcinoma |
0.04064387 |
Sensitive |
| ENSG00000230454.1 |
Methotrexate |
Colon adenocarcinoma |
0.010333386 |
Sensitive |
| ENSG00000230615.2 |
Methotrexate |
Colon adenocarcinoma |
0.011251334 |
Sensitive |
| ENSG00000230834.1 |
Methotrexate |
Colon adenocarcinoma |
0.007164618 |
Sensitive |
| ENSG00000231119.2 |
Methotrexate |
Colon adenocarcinoma |
0.023607996 |
Sensitive |
| ENSG00000231521.1 |
Methotrexate |
Colon adenocarcinoma |
0.013906669 |
Sensitive |
| ENSG00000231646.1 |
Methotrexate |
Colon adenocarcinoma |
0.006477805 |
Sensitive |
| ENSG00000232656.3 |
Methotrexate |
Colon adenocarcinoma |
0.042180815 |
Sensitive |
| ENSG00000234694.1 |
Methotrexate |
Colon adenocarcinoma |
0.002231071 |
Sensitive |
| ENSG00000237248.3 |
Methotrexate |
Colon adenocarcinoma |
0.035107672 |
Sensitive |
| ENSG00000245694.4 |
Methotrexate |
Colon adenocarcinoma |
0.044677677 |
Sensitive |
| ENSG00000245711.2 |
Methotrexate |
Colon adenocarcinoma |
0.038469047 |
Sensitive |
| ENSG00000246323.2 |
Methotrexate |
Colon adenocarcinoma |
0.020646725 |
Sensitive |
| ENSG00000248489.1 |
Methotrexate |
Colon adenocarcinoma |
0.026383775 |
Sensitive |
| ENSG00000249655.1 |
Methotrexate |
Colon adenocarcinoma |
0.029561959 |
Sensitive |
| ENSG00000250069.1 |
Methotrexate |
Colon adenocarcinoma |
0.027364426 |
Sensitive |
| ENSG00000250900.2 |
Methotrexate |
Colon adenocarcinoma |
0.00919806 |
Sensitive |
| ENSG00000253764.1 |
Methotrexate |
Colon adenocarcinoma |
0.047646779 |
Sensitive |
| ENSG00000256546.1 |
Methotrexate |
Colon adenocarcinoma |
0.008039806 |
Sensitive |
| ENSG00000256789.1 |
Methotrexate |
Colon adenocarcinoma |
0.015249422 |
Sensitive |
| ENSG00000257534.1 |
Methotrexate |
Colon adenocarcinoma |
0.041960559 |
Sensitive |
| ENSG00000259709.1 |
Methotrexate |
Colon adenocarcinoma |
0.030947274 |
Sensitive |
| ENSG00000260088.1 |
Methotrexate |
Colon adenocarcinoma |
0.040949366 |
Sensitive |
| ENSG00000260949.1 |
Methotrexate |
Colon adenocarcinoma |
0.009863076 |
Sensitive |
| ENSG00000261542.1 |
Methotrexate |
Colon adenocarcinoma |
0.017745076 |
Sensitive |
| ENSG00000261574.1 |
Methotrexate |
Colon adenocarcinoma |
0.015888549 |
Sensitive |
| ENSG00000262903.1 |
Methotrexate |
Colon adenocarcinoma |
0.007299866 |
Sensitive |
| ENSG00000263004.1 |
Methotrexate |
Colon adenocarcinoma |
0.034359304 |
Sensitive |
| ENSG00000263272.1 |
Methotrexate |
Colon adenocarcinoma |
0.02821167 |
Sensitive |
| ENSG00000263280.1 |
Methotrexate |
Colon adenocarcinoma |
0.041589921 |
Sensitive |
| ENSG00000263345.1 |
Methotrexate |
Colon adenocarcinoma |
0.017859812 |
Sensitive |
| ENSG00000264290.1 |
Methotrexate |
Colon adenocarcinoma |
0.044060202 |
Sensitive |
| ENSG00000264486.1 |
Methotrexate |
Colon adenocarcinoma |
0.040952639 |
Sensitive |
| ENSG00000264548.1 |
Methotrexate |
Colon adenocarcinoma |
0.026092475 |
Sensitive |
| ENSG00000265394.1 |
Methotrexate |
Colon adenocarcinoma |
0.049750941 |
Sensitive |
| ENSG00000265443.1 |
Methotrexate |
Colon adenocarcinoma |
0.0380974 |
Sensitive |
| ENSG00000265749.1 |
Methotrexate |
Colon adenocarcinoma |
0.019952054 |
Sensitive |
| ENSG00000265791.1 |
Methotrexate |
Colon adenocarcinoma |
0.028388342 |
Sensitive |
| ENSG00000265908.1 |
Methotrexate |
Colon adenocarcinoma |
0.017838221 |
Sensitive |
| ENSG00000266313.1 |
Methotrexate |
Colon adenocarcinoma |
0.049458193 |
Sensitive |
| ENSG00000267255.1 |
Methotrexate |
Colon adenocarcinoma |
0.035929863 |
Sensitive |
| ENSG00000268836.1 |
Methotrexate |
Colon adenocarcinoma |
0.018432479 |
Sensitive |
| ENSG00000269091.1 |
Methotrexate |
Colon adenocarcinoma |
0.038281773 |
Sensitive |
| ENSG00000271757.1 |
Methotrexate |
Colon adenocarcinoma |
0.019600487 |
Sensitive |
| ENSG00000271788.1 |
Methotrexate |
Colon adenocarcinoma |
0.04871035 |
Sensitive |
| ENSG00000272128.1 |
Methotrexate |
Colon adenocarcinoma |
0.031254722 |
Sensitive |
| ENSG00000272156.1 |
Methotrexate |
Colon adenocarcinoma |
0.043752149 |
Sensitive |
| ENSG00000272420.1 |
Methotrexate |
Colon adenocarcinoma |
0.040612855 |
Sensitive |
| ENSG00000272498.1 |
Methotrexate |
Colon adenocarcinoma |
0.030161083 |
Sensitive |
| ENSG00000272518.1 |
Methotrexate |
Colon adenocarcinoma |
0.03967454 |
Sensitive |
| ENSG00000272576.1 |
Methotrexate |
Colon adenocarcinoma |
0.031777236 |
Sensitive |
| ENSG00000272659.1 |
Methotrexate |
Colon adenocarcinoma |
0.01793571 |
Sensitive |
| ENSG00000197989.9 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015813429 |
Sensitive |
| ENSG00000204802.3 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021507695 |
Sensitive |
| ENSG00000214049.6 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026538932 |
Sensitive |
| ENSG00000224138.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038318342 |
Sensitive |
| ENSG00000224844.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034025948 |
Sensitive |
| ENSG00000225146.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027810085 |
Sensitive |
| ENSG00000225602.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009846773 |
Sensitive |
| ENSG00000226007.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026767273 |
Sensitive |
| ENSG00000226649.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029079608 |
Sensitive |
| ENSG00000227359.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044739687 |
Sensitive |
| ENSG00000227589.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006400896 |
Sensitive |
| ENSG00000229848.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010909711 |
Sensitive |
| ENSG00000230368.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044191571 |
Sensitive |
| ENSG00000230606.6 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013169136 |
Sensitive |
| ENSG00000232072.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001391396 |
Sensitive |
| ENSG00000232811.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015671642 |
Sensitive |
| ENSG00000232956.4 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049571881 |
Sensitive |
| ENSG00000234185.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024112556 |
Sensitive |
| ENSG00000235910.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002376041 |
Sensitive |
| ENSG00000237017.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021363778 |
Sensitive |
| ENSG00000237531.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017645282 |
Sensitive |
| ENSG00000237737.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017466141 |
Sensitive |
| ENSG00000237781.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037614897 |
Sensitive |
| ENSG00000237934.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018780416 |
Sensitive |
| ENSG00000241481.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045690882 |
Sensitive |
| ENSG00000242474.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048347423 |
Sensitive |
| ENSG00000242797.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023273503 |
Sensitive |
| ENSG00000244063.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009057112 |
Sensitive |
| ENSG00000245059.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011059315 |
Sensitive |
| ENSG00000245598.2 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004505975 |
Sensitive |
| ENSG00000248112.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031690254 |
Sensitive |
| ENSG00000249825.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018135731 |
Sensitive |
| ENSG00000250027.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018938548 |
Sensitive |
| ENSG00000254180.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023218461 |
Sensitive |
| ENSG00000255741.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04460635 |
Sensitive |
| ENSG00000260316.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034596215 |
Sensitive |
| ENSG00000260927.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027997306 |
Sensitive |
| ENSG00000261654.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009558394 |
Sensitive |
| ENSG00000261723.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006897478 |
Sensitive |
| ENSG00000261770.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037728872 |
Sensitive |
| ENSG00000266933.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025365439 |
Sensitive |
| ENSG00000267141.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001695597 |
Sensitive |
| ENSG00000267302.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04793454 |
Sensitive |
| ENSG00000268401.1 |
Methotrexate |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001388723 |
Sensitive |
| ENSG00000131484.3 |
Methotrexate |
Esophageal cancer |
0.00853433 |
Sensitive |
| ENSG00000177640.11 |
Methotrexate |
Esophageal cancer |
0.016309514 |
Sensitive |
| ENSG00000178193.5 |
Methotrexate |
Esophageal cancer |
0.021912019 |
Sensitive |
| ENSG00000179743.2 |
Methotrexate |
Esophageal cancer |
0.035106174 |
Sensitive |
| ENSG00000179818.9 |
Methotrexate |
Esophageal cancer |
0.041154886 |
Sensitive |
| ENSG00000185837.3 |
Methotrexate |
Esophageal cancer |
0.045915687 |
Sensitive |
| ENSG00000197989.9 |
Methotrexate |
Esophageal cancer |
0.017626637 |
Sensitive |
| ENSG00000203362.2 |
Methotrexate |
Esophageal cancer |
0.045090964 |
Sensitive |
| ENSG00000203499.6 |
Methotrexate |
Esophageal cancer |
0.0014749 |
Sensitive |
| ENSG00000213793.3 |
Methotrexate |
Esophageal cancer |
0.027574956 |
Sensitive |
| ENSG00000214293.4 |
Methotrexate |
Esophageal cancer |
0.015144449 |
Sensitive |
| ENSG00000215424.5 |
Methotrexate |
Esophageal cancer |
0.048285324 |
Sensitive |
| ENSG00000217576.7 |
Methotrexate |
Esophageal cancer |
0.015314759 |
Sensitive |
| ENSG00000218510.3 |
Methotrexate |
Esophageal cancer |
0.041378524 |
Sensitive |
| ENSG00000223473.1 |
Methotrexate |
Esophageal cancer |
0.046275767 |
Sensitive |
| ENSG00000223482.3 |
Methotrexate |
Esophageal cancer |
0.04814152 |
Sensitive |
| ENSG00000223528.3 |
Methotrexate |
Esophageal cancer |
0.04625623 |
Sensitive |
| ENSG00000223821.1 |
Methotrexate |
Esophageal cancer |
0.022977723 |
Sensitive |
| ENSG00000224281.4 |
Methotrexate |
Esophageal cancer |
0.044066471 |
Sensitive |
| ENSG00000224429.3 |
Methotrexate |
Esophageal cancer |
0.001168186 |
Sensitive |
| ENSG00000224597.5 |
Methotrexate |
Esophageal cancer |
0.003303633 |
Sensitive |
| ENSG00000224969.1 |
Methotrexate |
Esophageal cancer |
0.046894371 |
Sensitive |
| ENSG00000225484.2 |
Methotrexate |
Esophageal cancer |
0.011282536 |
Sensitive |
| ENSG00000225733.1 |
Methotrexate |
Esophageal cancer |
0.022241225 |
Sensitive |
| ENSG00000225891.1 |
Methotrexate |
Esophageal cancer |
0.031673343 |
Sensitive |
| ENSG00000225973.3 |
Methotrexate |
Esophageal cancer |
0.008154655 |
Sensitive |
| ENSG00000226756.1 |
Methotrexate |
Esophageal cancer |
0.004029961 |
Sensitive |
| ENSG00000226950.2 |
Methotrexate |
Esophageal cancer |
0.042182818 |
Sensitive |
| ENSG00000227479.1 |
Methotrexate |
Esophageal cancer |
0.03019189 |
Sensitive |
| ENSG00000227527.2 |
Methotrexate |
Esophageal cancer |
0.04381591 |
Sensitive |
| ENSG00000227540.1 |
Methotrexate |
Esophageal cancer |
0.045640402 |
Sensitive |
| ENSG00000227598.1 |
Methotrexate |
Esophageal cancer |
0.020311171 |
Sensitive |
| ENSG00000227678.3 |
Methotrexate |
Esophageal cancer |
0.028880815 |
Sensitive |
| ENSG00000227698.1 |
Methotrexate |
Esophageal cancer |
0.034591314 |
Sensitive |
| ENSG00000227946.1 |
Methotrexate |
Esophageal cancer |
0.024942992 |
Sensitive |
| ENSG00000227963.1 |
Methotrexate |
Esophageal cancer |
0.015704091 |
Sensitive |
| ENSG00000228265.1 |
Methotrexate |
Esophageal cancer |
0.030841002 |
Sensitive |
| ENSG00000228393.3 |
Methotrexate |
Esophageal cancer |
0.007949287 |
Sensitive |
| ENSG00000228561.2 |
Methotrexate |
Esophageal cancer |
0.040046596 |
Sensitive |
| ENSG00000228630.1 |
Methotrexate |
Esophageal cancer |
0.04079407 |
Sensitive |
| ENSG00000228865.1 |
Methotrexate |
Esophageal cancer |
0.003060365 |
Sensitive |
| ENSG00000228973.1 |
Methotrexate |
Esophageal cancer |
0.044506543 |
Sensitive |
| ENSG00000228989.1 |
Methotrexate |
Esophageal cancer |
0.013794218 |
Sensitive |
| ENSG00000229122.1 |
Methotrexate |
Esophageal cancer |
0.003044363 |
Sensitive |
| ENSG00000229178.1 |
Methotrexate |
Esophageal cancer |
0.018889326 |
Sensitive |
| ENSG00000229839.2 |
Methotrexate |
Esophageal cancer |
0.026520713 |
Sensitive |
| ENSG00000229841.1 |
Methotrexate |
Esophageal cancer |
0.030969869 |
Sensitive |
| ENSG00000230082.1 |
Methotrexate |
Esophageal cancer |
0.035014177 |
Sensitive |
| ENSG00000230424.1 |
Methotrexate |
Esophageal cancer |
0.027461603 |
Sensitive |
| ENSG00000230844.2 |
Methotrexate |
Esophageal cancer |
0.043134149 |
Sensitive |
| ENSG00000231010.1 |
Methotrexate |
Esophageal cancer |
0.016155726 |
Sensitive |
| ENSG00000231607.4 |
Methotrexate |
Esophageal cancer |
0.015645159 |
Sensitive |
| ENSG00000231611.1 |
Methotrexate |
Esophageal cancer |
0.034966651 |
Sensitive |
| ENSG00000231856.1 |
Methotrexate |
Esophageal cancer |
0.043866311 |
Sensitive |
| ENSG00000232093.1 |
Methotrexate |
Esophageal cancer |
0.027584354 |
Sensitive |
| ENSG00000232300.1 |
Methotrexate |
Esophageal cancer |
0.005837753 |
Sensitive |
| ENSG00000232453.1 |
Methotrexate |
Esophageal cancer |
0.043707336 |
Sensitive |
| ENSG00000232732.5 |
Methotrexate |
Esophageal cancer |
0.030266496 |
Sensitive |
| ENSG00000232860.3 |
Methotrexate |
Esophageal cancer |
0.028580057 |
Sensitive |
| ENSG00000232936.1 |
Methotrexate |
Esophageal cancer |
0.00119882 |
Sensitive |
| ENSG00000233429.5 |
Methotrexate |
Esophageal cancer |
0.03828159 |
Sensitive |
| ENSG00000233825.1 |
Methotrexate |
Esophageal cancer |
0.024210368 |
Sensitive |
| ENSG00000234160.1 |
Methotrexate |
Esophageal cancer |
0.013736 |
Sensitive |
| ENSG00000234753.1 |
Methotrexate |
Esophageal cancer |
0.023397842 |
Sensitive |
| ENSG00000235204.1 |
Methotrexate |
Esophageal cancer |
0.030698862 |
Sensitive |
| ENSG00000235381.1 |
Methotrexate |
Esophageal cancer |
0.032382044 |
Sensitive |
| ENSG00000235408.2 |
Methotrexate |
Esophageal cancer |
0.018522843 |
Sensitive |
| ENSG00000235427.1 |
Methotrexate |
Esophageal cancer |
0.035864956 |
Sensitive |
| ENSG00000236200.1 |
Methotrexate |
Esophageal cancer |
0.016479088 |
Sensitive |
| ENSG00000236242.1 |
Methotrexate |
Esophageal cancer |
0.022102558 |
Sensitive |
| ENSG00000236337.1 |
Methotrexate |
Esophageal cancer |
0.042088159 |
Sensitive |
| ENSG00000236869.1 |
Methotrexate |
Esophageal cancer |
0.012546943 |
Sensitive |
| ENSG00000236896.1 |
Methotrexate |
Esophageal cancer |
0.031813293 |
Sensitive |
| ENSG00000236991.2 |
Methotrexate |
Esophageal cancer |
0.027296438 |
Sensitive |
| ENSG00000237502.2 |
Methotrexate |
Esophageal cancer |
0.031938552 |
Sensitive |
| ENSG00000237857.2 |
Methotrexate |
Esophageal cancer |
0.019003275 |
Sensitive |
| ENSG00000237934.1 |
Methotrexate |
Esophageal cancer |
0.0036408 |
Sensitive |
| ENSG00000237943.2 |
Methotrexate |
Esophageal cancer |
0.003292189 |
Sensitive |
| ENSG00000240571.1 |
Methotrexate |
Esophageal cancer |
0.012134585 |
Sensitive |
| ENSG00000241764.3 |
Methotrexate |
Esophageal cancer |
0.007207144 |
Sensitive |
| ENSG00000242288.6 |
Methotrexate |
Esophageal cancer |
0.002893311 |
Sensitive |
| ENSG00000244184.1 |
Methotrexate |
Esophageal cancer |
0.034067398 |
Sensitive |
| ENSG00000244268.1 |
Methotrexate |
Esophageal cancer |
0.042776459 |
Sensitive |
| ENSG00000244300.2 |
Methotrexate |
Esophageal cancer |
0.046495773 |
Sensitive |
| ENSG00000244393.3 |
Methotrexate |
Esophageal cancer |
0.007498233 |
Sensitive |
| ENSG00000244733.4 |
Methotrexate |
Esophageal cancer |
0.002728128 |
Sensitive |
| ENSG00000246323.2 |
Methotrexate |
Esophageal cancer |
0.049913059 |
Sensitive |
| ENSG00000246898.1 |
Methotrexate |
Esophageal cancer |
0.024115666 |
Sensitive |
| ENSG00000247092.2 |
Methotrexate |
Esophageal cancer |
0.04334953 |
Sensitive |
| ENSG00000247271.2 |
Methotrexate |
Esophageal cancer |
0.037691648 |
Sensitive |
| ENSG00000248092.3 |
Methotrexate |
Esophageal cancer |
0.018040396 |
Sensitive |
| ENSG00000248265.1 |
Methotrexate |
Esophageal cancer |
0.026149873 |
Sensitive |
| ENSG00000249868.4 |
Methotrexate |
Esophageal cancer |
0.014664533 |
Sensitive |
| ENSG00000250899.3 |
Methotrexate |
Esophageal cancer |
0.028495614 |
Sensitive |
| ENSG00000250988.3 |
Methotrexate |
Esophageal cancer |
0.045438013 |
Sensitive |
| ENSG00000251022.2 |
Methotrexate |
Esophageal cancer |
0.042638698 |
Sensitive |
| ENSG00000251323.2 |
Methotrexate |
Esophageal cancer |
0.039587054 |
Sensitive |
| ENSG00000253187.2 |
Methotrexate |
Esophageal cancer |
0.012445875 |
Sensitive |
| ENSG00000253327.2 |
Methotrexate |
Esophageal cancer |
0.048626271 |
Sensitive |
| ENSG00000253392.2 |
Methotrexate |
Esophageal cancer |
0.046030278 |
Sensitive |
| ENSG00000253508.1 |
Methotrexate |
Esophageal cancer |
0.032033599 |
Sensitive |
| ENSG00000253559.1 |
Methotrexate |
Esophageal cancer |
0.019048097 |
Sensitive |
| ENSG00000253716.1 |
Methotrexate |
Esophageal cancer |
0.00411608 |
Sensitive |
| ENSG00000254428.1 |
Methotrexate |
Esophageal cancer |
0.032839553 |
Sensitive |
| ENSG00000254635.1 |
Methotrexate |
Esophageal cancer |
0.023409932 |
Sensitive |
| ENSG00000255121.2 |
Methotrexate |
Esophageal cancer |
0.026020471 |
Sensitive |
| ENSG00000255153.1 |
Methotrexate |
Esophageal cancer |
0.007046918 |
Sensitive |
| ENSG00000255198.3 |
Methotrexate |
Esophageal cancer |
0.017759138 |
Sensitive |
| ENSG00000255320.1 |
Methotrexate |
Esophageal cancer |
0.001488114 |
Sensitive |
| ENSG00000255409.1 |
Methotrexate |
Esophageal cancer |
0.031730617 |
Sensitive |
| ENSG00000255717.2 |
Methotrexate |
Esophageal cancer |
0.00814834 |
Sensitive |
| ENSG00000256299.1 |
Methotrexate |
Esophageal cancer |
0.041516788 |
Sensitive |
| ENSG00000256442.1 |
Methotrexate |
Esophageal cancer |
0.006830141 |
Sensitive |
| ENSG00000257222.1 |
Methotrexate |
Esophageal cancer |
0.025603436 |
Sensitive |
| ENSG00000257509.1 |
Methotrexate |
Esophageal cancer |
0.046169921 |
Sensitive |
| ENSG00000257953.1 |
Methotrexate |
Esophageal cancer |
0.033023204 |
Sensitive |
| ENSG00000258428.1 |
Methotrexate |
Esophageal cancer |
0.046389826 |
Sensitive |
| ENSG00000258798.1 |
Methotrexate |
Esophageal cancer |
0.032692473 |
Sensitive |
| ENSG00000259758.1 |
Methotrexate |
Esophageal cancer |
0.008454543 |
Sensitive |
| ENSG00000259802.1 |
Methotrexate |
Esophageal cancer |
0.040279576 |
Sensitive |
| ENSG00000259826.1 |
Methotrexate |
Esophageal cancer |
0.030747795 |
Sensitive |
| ENSG00000259865.1 |
Methotrexate |
Esophageal cancer |
0.032503309 |
Sensitive |
| ENSG00000259943.1 |
Methotrexate |
Esophageal cancer |
0.036729647 |
Sensitive |
| ENSG00000260022.1 |
Methotrexate |
Esophageal cancer |
0.004442386 |
Sensitive |
| ENSG00000260156.1 |
Methotrexate |
Esophageal cancer |
0.011071829 |
Sensitive |
| ENSG00000260219.1 |
Methotrexate |
Esophageal cancer |
0.037740121 |
Sensitive |
| ENSG00000260228.1 |
Methotrexate |
Esophageal cancer |
0.044174452 |
Sensitive |
| ENSG00000260260.1 |
Methotrexate |
Esophageal cancer |
0.039061043 |
Sensitive |
| ENSG00000260273.1 |
Methotrexate |
Esophageal cancer |
0.049541138 |
Sensitive |
| ENSG00000260293.1 |
Methotrexate |
Esophageal cancer |
0.026483107 |
Sensitive |
| ENSG00000260306.1 |
Methotrexate |
Esophageal cancer |
0.033969964 |
Sensitive |
| ENSG00000260578.1 |
Methotrexate |
Esophageal cancer |
0.014286913 |
Sensitive |
| ENSG00000260589.1 |
Methotrexate |
Esophageal cancer |
0.049946051 |
Sensitive |
| ENSG00000260619.1 |
Methotrexate |
Esophageal cancer |
0.035016697 |
Sensitive |
| ENSG00000260805.1 |
Methotrexate |
Esophageal cancer |
0.033366259 |
Sensitive |
| ENSG00000260905.1 |
Methotrexate |
Esophageal cancer |
0.036336788 |
Sensitive |
| ENSG00000260917.1 |
Methotrexate |
Esophageal cancer |
0.015342255 |
Sensitive |
| ENSG00000260924.2 |
Methotrexate |
Esophageal cancer |
0.048560158 |
Sensitive |
| ENSG00000260954.1 |
Methotrexate |
Esophageal cancer |
0.005719892 |
Sensitive |
| ENSG00000261005.1 |
Methotrexate |
Esophageal cancer |
0.019887526 |
Sensitive |
| ENSG00000261096.1 |
Methotrexate |
Esophageal cancer |
0.048574989 |
Sensitive |
| ENSG00000261101.1 |
Methotrexate |
Esophageal cancer |
0.009193252 |
Sensitive |
| ENSG00000261141.1 |
Methotrexate |
Esophageal cancer |
0.04303111 |
Sensitive |
| ENSG00000261338.1 |
Methotrexate |
Esophageal cancer |
0.013669834 |
Sensitive |
| ENSG00000261396.1 |
Methotrexate |
Esophageal cancer |
0.035206782 |
Sensitive |
| ENSG00000261420.1 |
Methotrexate |
Esophageal cancer |
0.037375782 |
Sensitive |
| ENSG00000261428.1 |
Methotrexate |
Esophageal cancer |
0.004907577 |
Sensitive |
| ENSG00000261526.1 |
Methotrexate |
Esophageal cancer |
0.007103778 |
Sensitive |
| ENSG00000261542.1 |
Methotrexate |
Esophageal cancer |
0.027017331 |
Sensitive |
| ENSG00000261731.2 |
Methotrexate |
Esophageal cancer |
0.023302758 |
Sensitive |
| ENSG00000261840.1 |
Methotrexate |
Esophageal cancer |
0.028347036 |
Sensitive |
| ENSG00000262298.1 |
Methotrexate |
Esophageal cancer |
0.010774793 |
Sensitive |
| ENSG00000262412.1 |
Methotrexate |
Esophageal cancer |
0.010372745 |
Sensitive |
| ENSG00000262477.1 |
Methotrexate |
Esophageal cancer |
0.010478383 |
Sensitive |
| ENSG00000262514.1 |
Methotrexate |
Esophageal cancer |
0.010882008 |
Sensitive |
| ENSG00000263069.1 |
Methotrexate |
Esophageal cancer |
0.043015321 |
Sensitive |
| ENSG00000263350.1 |
Methotrexate |
Esophageal cancer |
0.013525979 |
Sensitive |
| ENSG00000263718.2 |
Methotrexate |
Esophageal cancer |
0.047655228 |
Sensitive |
| ENSG00000263731.1 |
Methotrexate |
Esophageal cancer |
0.004198603 |
Sensitive |
| ENSG00000263859.1 |
Methotrexate |
Esophageal cancer |
0.017702076 |
Sensitive |
| ENSG00000264207.1 |
Methotrexate |
Esophageal cancer |
0.049981155 |
Sensitive |
| ENSG00000264247.1 |
Methotrexate |
Esophageal cancer |
0.03652219 |
Sensitive |
| ENSG00000264339.1 |
Methotrexate |
Esophageal cancer |
0.031974561 |
Sensitive |
| ENSG00000265242.1 |
Methotrexate |
Esophageal cancer |
0.022251395 |
Sensitive |
| ENSG00000265688.1 |
Methotrexate |
Esophageal cancer |
0.009243444 |
Sensitive |
| ENSG00000265800.1 |
Methotrexate |
Esophageal cancer |
0.034385249 |
Sensitive |
| ENSG00000266473.1 |
Methotrexate |
Esophageal cancer |
0.033654714 |
Sensitive |
| ENSG00000267100.1 |
Methotrexate |
Esophageal cancer |
0.029111635 |
Sensitive |
| ENSG00000267197.1 |
Methotrexate |
Esophageal cancer |
0.030310976 |
Sensitive |
| ENSG00000267232.1 |
Methotrexate |
Esophageal cancer |
0.008117161 |
Sensitive |
| ENSG00000267321.1 |
Methotrexate |
Esophageal cancer |
0.020670301 |
Sensitive |
| ENSG00000267394.1 |
Methotrexate |
Esophageal cancer |
0.003006687 |
Sensitive |
| ENSG00000267504.1 |
Methotrexate |
Esophageal cancer |
0.017973848 |
Sensitive |
| ENSG00000267655.1 |
Methotrexate |
Esophageal cancer |
0.04245864 |
Sensitive |
| ENSG00000267940.1 |
Methotrexate |
Esophageal cancer |
0.000583552 |
Sensitive |
| ENSG00000268006.1 |
Methotrexate |
Esophageal cancer |
0.001907774 |
Sensitive |
| ENSG00000268340.1 |
Methotrexate |
Esophageal cancer |
0.041507201 |
Sensitive |
| ENSG00000268362.1 |
Methotrexate |
Esophageal cancer |
0.021450376 |
Sensitive |
| ENSG00000268364.1 |
Methotrexate |
Esophageal cancer |
0.025687011 |
Sensitive |
| ENSG00000268912.1 |
Methotrexate |
Esophageal cancer |
0.025868107 |
Sensitive |
| ENSG00000269038.1 |
Methotrexate |
Esophageal cancer |
0.040074351 |
Sensitive |
| ENSG00000269293.2 |
Methotrexate |
Esophageal cancer |
0.035347784 |
Sensitive |
| ENSG00000269386.1 |
Methotrexate |
Esophageal cancer |
0.033666885 |
Sensitive |
| ENSG00000269609.1 |
Methotrexate |
Esophageal cancer |
0.043340164 |
Sensitive |
| ENSG00000269646.1 |
Methotrexate |
Esophageal cancer |
0.006687922 |
Sensitive |
| ENSG00000269925.1 |
Methotrexate |
Esophageal cancer |
0.016715214 |
Sensitive |
| ENSG00000270006.1 |
Methotrexate |
Esophageal cancer |
0.015343914 |
Sensitive |
| ENSG00000270018.1 |
Methotrexate |
Esophageal cancer |
0.029582451 |
Sensitive |
| ENSG00000270081.1 |
Methotrexate |
Esophageal cancer |
0.01189507 |
Sensitive |
| ENSG00000270145.1 |
Methotrexate |
Esophageal cancer |
0.002970769 |
Sensitive |
| ENSG00000270159.1 |
Methotrexate |
Esophageal cancer |
0.044349077 |
Sensitive |
| ENSG00000270170.1 |
Methotrexate |
Esophageal cancer |
0.008873276 |
Sensitive |
| ENSG00000270949.1 |
Methotrexate |
Esophageal cancer |
0.009422547 |
Sensitive |
| ENSG00000271119.1 |
Methotrexate |
Esophageal cancer |
0.042180283 |
Sensitive |
| ENSG00000271133.1 |
Methotrexate |
Esophageal cancer |
0.043518222 |
Sensitive |
| ENSG00000271185.1 |
Methotrexate |
Esophageal cancer |
0.006526006 |
Sensitive |
| ENSG00000271199.1 |
Methotrexate |
Esophageal cancer |
0.010592118 |
Sensitive |
| ENSG00000271551.1 |
Methotrexate |
Esophageal cancer |
0.034793041 |
Sensitive |
| ENSG00000271659.1 |
Methotrexate |
Esophageal cancer |
0.016703064 |
Sensitive |
| ENSG00000271816.1 |
Methotrexate |
Esophageal cancer |
0.003126478 |
Sensitive |
| ENSG00000271851.1 |
Methotrexate |
Esophageal cancer |
0.031079131 |
Sensitive |
| ENSG00000271888.1 |
Methotrexate |
Esophageal cancer |
0.03221736 |
Sensitive |
| ENSG00000271948.1 |
Methotrexate |
Esophageal cancer |
0.003536761 |
Sensitive |
| ENSG00000272029.1 |
Methotrexate |
Esophageal cancer |
0.03441906 |
Sensitive |
| ENSG00000272077.1 |
Methotrexate |
Esophageal cancer |
0.010813018 |
Sensitive |
| ENSG00000272140.2 |
Methotrexate |
Esophageal cancer |
0.010260347 |
Sensitive |
| ENSG00000272172.1 |
Methotrexate |
Esophageal cancer |
0.022936354 |
Sensitive |
| ENSG00000272225.1 |
Methotrexate |
Esophageal cancer |
0.031012627 |
Sensitive |
| ENSG00000272301.1 |
Methotrexate |
Esophageal cancer |
0.021159265 |
Sensitive |
| ENSG00000272308.1 |
Methotrexate |
Esophageal cancer |
0.024026934 |
Sensitive |
| ENSG00000272335.1 |
Methotrexate |
Esophageal cancer |
0.012084713 |
Sensitive |
| ENSG00000272440.1 |
Methotrexate |
Esophageal cancer |
0.014224167 |
Sensitive |
| ENSG00000272520.1 |
Methotrexate |
Esophageal cancer |
0.018742421 |
Sensitive |
| ENSG00000272523.1 |
Methotrexate |
Esophageal cancer |
0.026405184 |
Sensitive |
| ENSG00000272524.1 |
Methotrexate |
Esophageal cancer |
0.030611071 |
Sensitive |
| ENSG00000272576.1 |
Methotrexate |
Esophageal cancer |
0.001029043 |
Sensitive |
| ENSG00000272604.1 |
Methotrexate |
Esophageal cancer |
0.002167277 |
Sensitive |
| ENSG00000272644.1 |
Methotrexate |
Esophageal cancer |
0.037587562 |
Sensitive |
| ENSG00000272645.1 |
Methotrexate |
Esophageal cancer |
0.04617997 |
Sensitive |
| ENSG00000272663.1 |
Methotrexate |
Esophageal cancer |
0.049255942 |
Sensitive |
| ENSG00000272721.1 |
Methotrexate |
Esophageal cancer |
0.00349185 |
Sensitive |
| ENSG00000272744.1 |
Methotrexate |
Esophageal cancer |
0.045777501 |
Sensitive |
| ENSG00000272788.1 |
Methotrexate |
Esophageal cancer |
0.047558211 |
Sensitive |
| ENSG00000272800.1 |
Methotrexate |
Esophageal cancer |
0.018193042 |
Sensitive |
| ENSG00000272853.1 |
Methotrexate |
Esophageal cancer |
0.027448085 |
Sensitive |
| ENSG00000272945.1 |
Methotrexate |
Esophageal cancer |
0.003951963 |
Sensitive |
| ENSG00000273004.1 |
Methotrexate |
Esophageal cancer |
0.011081622 |
Sensitive |
| ENSG00000273026.1 |
Methotrexate |
Esophageal cancer |
0.03057322 |
Sensitive |
| ENSG00000273142.1 |
Methotrexate |
Esophageal cancer |
0.038961681 |
Sensitive |
| ENSG00000273162.1 |
Methotrexate |
Esophageal cancer |
0.016590744 |
Sensitive |
| ENSG00000273230.1 |
Methotrexate |
Esophageal cancer |
0.025129254 |
Sensitive |
| ENSG00000273335.1 |
Methotrexate |
Esophageal cancer |
0.018820307 |
Sensitive |
| ENSG00000273343.1 |
Methotrexate |
Esophageal cancer |
0.040835183 |
Sensitive |
| ENSG00000273456.1 |
Methotrexate |
Esophageal cancer |
0.045774392 |
Sensitive |
| ENSG00000177410.8 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.001680294 |
Sensitive |
| ENSG00000225172.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.048072085 |
Sensitive |
| ENSG00000226380.3 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.022296733 |
Sensitive |
| ENSG00000226578.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.044431889 |
Sensitive |
| ENSG00000228141.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.040384092 |
Sensitive |
| ENSG00000229950.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.042935911 |
Sensitive |
| ENSG00000231768.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.037423323 |
Sensitive |
| ENSG00000232224.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.044579238 |
Sensitive |
| ENSG00000236066.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.022434704 |
Sensitive |
| ENSG00000251867.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.044870136 |
Sensitive |
| ENSG00000257698.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.046076856 |
Sensitive |
| ENSG00000258479.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.043746794 |
Sensitive |
| ENSG00000259242.2 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.04008804 |
Sensitive |
| ENSG00000259792.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.047999644 |
Sensitive |
| ENSG00000260083.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.037793736 |
Sensitive |
| ENSG00000260296.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.03693398 |
Sensitive |
| ENSG00000268458.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.005947735 |
Sensitive |
| ENSG00000268568.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.012017158 |
Sensitive |
| ENSG00000269947.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.047982569 |
Sensitive |
| ENSG00000270659.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.045479082 |
Sensitive |
| ENSG00000270681.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.019090248 |
Sensitive |
| ENSG00000272264.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.045834907 |
Sensitive |
| ENSG00000272567.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.030485926 |
Sensitive |
| ENSG00000272859.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.046304317 |
Sensitive |
| ENSG00000273449.1 |
Methotrexate |
Chronic Lymphocytic Leukemia |
0.021086622 |
Sensitive |
| ENSG00000131484.3 |
Methotrexate |
Brain lower grade glioma |
0.044748806 |
Sensitive |
| ENSG00000152487.6 |
Methotrexate |
Brain lower grade glioma |
0.026895165 |
Sensitive |
| ENSG00000163597.10 |
Methotrexate |
Brain lower grade glioma |
0.031759116 |
Sensitive |
| ENSG00000173867.8 |
Methotrexate |
Brain lower grade glioma |
0.039962216 |
Sensitive |
| ENSG00000175061.13 |
Methotrexate |
Brain lower grade glioma |
0.009456472 |
Sensitive |
| ENSG00000175873.3 |
Methotrexate |
Brain lower grade glioma |
0.009339969 |
Sensitive |
| ENSG00000177410.8 |
Methotrexate |
Brain lower grade glioma |
0.047543712 |
Sensitive |
| ENSG00000177640.11 |
Methotrexate |
Brain lower grade glioma |
0.042116816 |
Sensitive |
| ENSG00000179818.9 |
Methotrexate |
Brain lower grade glioma |
0.025608901 |
Sensitive |
| ENSG00000181798.2 |
Methotrexate |
Brain lower grade glioma |
0.015742882 |
Sensitive |
| ENSG00000185044.10 |
Methotrexate |
Brain lower grade glioma |
0.015917066 |
Sensitive |
| ENSG00000185904.7 |
Methotrexate |
Brain lower grade glioma |
0.002153691 |
Sensitive |
| ENSG00000186615.6 |
Methotrexate |
Brain lower grade glioma |
0.020877057 |
Sensitive |
| ENSG00000188825.9 |
Methotrexate |
Brain lower grade glioma |
0.037418364 |
Sensitive |
| ENSG00000196295.7 |
Methotrexate |
Brain lower grade glioma |
0.029614253 |
Sensitive |
| ENSG00000197210.7 |
Methotrexate |
Brain lower grade glioma |
0.033719835 |
Sensitive |
| ENSG00000203496.4 |
Methotrexate |
Brain lower grade glioma |
0.021876144 |
Sensitive |
| ENSG00000203739.3 |
Methotrexate |
Brain lower grade glioma |
0.028174227 |
Sensitive |
| ENSG00000205037.2 |
Methotrexate |
Brain lower grade glioma |
0.034462308 |
Sensitive |
| ENSG00000205041.1 |
Methotrexate |
Brain lower grade glioma |
0.010970567 |
Sensitive |
| ENSG00000212694.4 |
Methotrexate |
Brain lower grade glioma |
0.026576182 |
Sensitive |
| ENSG00000214293.4 |
Methotrexate |
Brain lower grade glioma |
0.03409844 |
Sensitive |
| ENSG00000214725.3 |
Methotrexate |
Brain lower grade glioma |
0.002060293 |
Sensitive |
| ENSG00000215424.5 |
Methotrexate |
Brain lower grade glioma |
0.012087418 |
Sensitive |
| ENSG00000217258.2 |
Methotrexate |
Brain lower grade glioma |
0.044184298 |
Sensitive |
| ENSG00000223482.3 |
Methotrexate |
Brain lower grade glioma |
0.044509214 |
Sensitive |
| ENSG00000224032.2 |
Methotrexate |
Brain lower grade glioma |
0.037390156 |
Sensitive |
| ENSG00000224043.3 |
Methotrexate |
Brain lower grade glioma |
0.03662738 |
Sensitive |
| ENSG00000224046.1 |
Methotrexate |
Brain lower grade glioma |
0.024876339 |
Sensitive |
| ENSG00000224079.1 |
Methotrexate |
Brain lower grade glioma |
0.022182726 |
Sensitive |
| ENSG00000224541.1 |
Methotrexate |
Brain lower grade glioma |
0.049124684 |
Sensitive |
| ENSG00000224635.1 |
Methotrexate |
Brain lower grade glioma |
0.023830472 |
Sensitive |
| ENSG00000224699.4 |
Methotrexate |
Brain lower grade glioma |
0.037900376 |
Sensitive |
| ENSG00000224738.1 |
Methotrexate |
Brain lower grade glioma |
0.032367827 |
Sensitive |
| ENSG00000224934.2 |
Methotrexate |
Brain lower grade glioma |
0.011718182 |
Sensitive |
| ENSG00000225057.2 |
Methotrexate |
Brain lower grade glioma |
0.038784235 |
Sensitive |
| ENSG00000225113.1 |
Methotrexate |
Brain lower grade glioma |
0.029873349 |
Sensitive |
| ENSG00000225173.1 |
Methotrexate |
Brain lower grade glioma |
0.027762341 |
Sensitive |
| ENSG00000225213.2 |
Methotrexate |
Brain lower grade glioma |
0.011310777 |
Sensitive |
| ENSG00000225218.1 |
Methotrexate |
Brain lower grade glioma |
0.041743018 |
Sensitive |
| ENSG00000225278.3 |
Methotrexate |
Brain lower grade glioma |
0.022342669 |
Sensitive |
| ENSG00000225411.2 |
Methotrexate |
Brain lower grade glioma |
0.047845953 |
Sensitive |
| ENSG00000225484.2 |
Methotrexate |
Brain lower grade glioma |
0.031937912 |
Sensitive |
| ENSG00000225518.2 |
Methotrexate |
Brain lower grade glioma |
0.044252157 |
Sensitive |
| ENSG00000225527.1 |
Methotrexate |
Brain lower grade glioma |
0.042019146 |
Sensitive |
| ENSG00000225806.3 |
Methotrexate |
Brain lower grade glioma |
0.016855994 |
Sensitive |
| ENSG00000226007.2 |
Methotrexate |
Brain lower grade glioma |
0.038727987 |
Sensitive |
| ENSG00000226009.1 |
Methotrexate |
Brain lower grade glioma |
0.033375341 |
Sensitive |
| ENSG00000226200.2 |
Methotrexate |
Brain lower grade glioma |
0.038855477 |
Sensitive |
| ENSG00000226310.1 |
Methotrexate |
Brain lower grade glioma |
0.023237255 |
Sensitive |
| ENSG00000226381.3 |
Methotrexate |
Brain lower grade glioma |
0.041200701 |
Sensitive |
| ENSG00000226688.2 |
Methotrexate |
Brain lower grade glioma |
0.041336729 |
Sensitive |
| ENSG00000226853.2 |
Methotrexate |
Brain lower grade glioma |
0.042068468 |
Sensitive |
| ENSG00000226877.3 |
Methotrexate |
Brain lower grade glioma |
0.047643845 |
Sensitive |
| ENSG00000226891.2 |
Methotrexate |
Brain lower grade glioma |
0.049511171 |
Sensitive |
| ENSG00000226950.2 |
Methotrexate |
Brain lower grade glioma |
0.011697269 |
Sensitive |
| ENSG00000227014.1 |
Methotrexate |
Brain lower grade glioma |
0.034855757 |
Sensitive |
| ENSG00000227028.2 |
Methotrexate |
Brain lower grade glioma |
0.027921292 |
Sensitive |
| ENSG00000227186.1 |
Methotrexate |
Brain lower grade glioma |
0.023973264 |
Sensitive |
| ENSG00000227409.1 |
Methotrexate |
Brain lower grade glioma |
0.011875396 |
Sensitive |
| ENSG00000227540.1 |
Methotrexate |
Brain lower grade glioma |
0.016647802 |
Sensitive |
| ENSG00000227543.3 |
Methotrexate |
Brain lower grade glioma |
0.040749974 |
Sensitive |
| ENSG00000227627.1 |
Methotrexate |
Brain lower grade glioma |
0.006082758 |
Sensitive |
| ENSG00000227896.2 |
Methotrexate |
Brain lower grade glioma |
0.017980789 |
Sensitive |
| ENSG00000227954.2 |
Methotrexate |
Brain lower grade glioma |
0.0431374 |
Sensitive |
| ENSG00000227963.1 |
Methotrexate |
Brain lower grade glioma |
0.017552258 |
Sensitive |
| ENSG00000228043.1 |
Methotrexate |
Brain lower grade glioma |
0.020181035 |
Sensitive |
| ENSG00000228084.1 |
Methotrexate |
Brain lower grade glioma |
0.042265648 |
Sensitive |
| ENSG00000228113.3 |
Methotrexate |
Brain lower grade glioma |
0.019611275 |
Sensitive |
| ENSG00000228137.1 |
Methotrexate |
Brain lower grade glioma |
0.021129818 |
Sensitive |
| ENSG00000228251.1 |
Methotrexate |
Brain lower grade glioma |
0.039155068 |
Sensitive |
| ENSG00000228302.2 |
Methotrexate |
Brain lower grade glioma |
0.020868851 |
Sensitive |
| ENSG00000228363.2 |
Methotrexate |
Brain lower grade glioma |
0.047148858 |
Sensitive |
| ENSG00000228506.1 |
Methotrexate |
Brain lower grade glioma |
0.035512451 |
Sensitive |
| ENSG00000228604.3 |
Methotrexate |
Brain lower grade glioma |
0.04358672 |
Sensitive |
| ENSG00000228614.1 |
Methotrexate |
Brain lower grade glioma |
0.007848888 |
Sensitive |
| ENSG00000228886.1 |
Methotrexate |
Brain lower grade glioma |
0.000867492 |
Sensitive |
| ENSG00000228906.1 |
Methotrexate |
Brain lower grade glioma |
0.038338333 |
Sensitive |
| ENSG00000228989.1 |
Methotrexate |
Brain lower grade glioma |
0.028402854 |
Sensitive |
| ENSG00000229178.1 |
Methotrexate |
Brain lower grade glioma |
0.017425358 |
Sensitive |
| ENSG00000229697.1 |
Methotrexate |
Brain lower grade glioma |
0.046900789 |
Sensitive |
| ENSG00000229953.1 |
Methotrexate |
Brain lower grade glioma |
0.025077052 |
Sensitive |
| ENSG00000229999.2 |
Methotrexate |
Brain lower grade glioma |
0.045940998 |
Sensitive |
| ENSG00000230021.3 |
Methotrexate |
Brain lower grade glioma |
0.049567828 |
Sensitive |
| ENSG00000230530.1 |
Methotrexate |
Brain lower grade glioma |
0.040784774 |
Sensitive |
| ENSG00000230552.1 |
Methotrexate |
Brain lower grade glioma |
0.042585158 |
Sensitive |
| ENSG00000230658.1 |
Methotrexate |
Brain lower grade glioma |
0.022423562 |
Sensitive |
| ENSG00000230724.5 |
Methotrexate |
Brain lower grade glioma |
0.032601748 |
Sensitive |
| ENSG00000230735.1 |
Methotrexate |
Brain lower grade glioma |
0.008695184 |
Sensitive |
| ENSG00000230850.3 |
Methotrexate |
Brain lower grade glioma |
0.003216733 |
Sensitive |
| ENSG00000230880.2 |
Methotrexate |
Brain lower grade glioma |
0.013522731 |
Sensitive |
| ENSG00000230896.1 |
Methotrexate |
Brain lower grade glioma |
0.017251429 |
Sensitive |
| ENSG00000231185.2 |
Methotrexate |
Brain lower grade glioma |
0.033392011 |
Sensitive |
| ENSG00000231473.2 |
Methotrexate |
Brain lower grade glioma |
0.032401832 |
Sensitive |
| ENSG00000231530.1 |
Methotrexate |
Brain lower grade glioma |
0.033379178 |
Sensitive |
| ENSG00000231616.4 |
Methotrexate |
Brain lower grade glioma |
0.01940863 |
Sensitive |
| ENSG00000231999.2 |
Methotrexate |
Brain lower grade glioma |
0.013159725 |
Sensitive |
| ENSG00000232019.1 |
Methotrexate |
Brain lower grade glioma |
0.039451835 |
Sensitive |
| ENSG00000232028.1 |
Methotrexate |
Brain lower grade glioma |
0.026592818 |
Sensitive |
| ENSG00000232274.2 |
Methotrexate |
Brain lower grade glioma |
0.025760819 |
Sensitive |
| ENSG00000232336.1 |
Methotrexate |
Brain lower grade glioma |
0.025796888 |
Sensitive |
| ENSG00000232485.2 |
Methotrexate |
Brain lower grade glioma |
0.0431702 |
Sensitive |
| ENSG00000232593.2 |
Methotrexate |
Brain lower grade glioma |
0.034405347 |
Sensitive |
| ENSG00000232677.2 |
Methotrexate |
Brain lower grade glioma |
0.021062938 |
Sensitive |
| ENSG00000232739.1 |
Methotrexate |
Brain lower grade glioma |
0.036944563 |
Sensitive |
| ENSG00000232936.1 |
Methotrexate |
Brain lower grade glioma |
0.007040759 |
Sensitive |
| ENSG00000232956.4 |
Methotrexate |
Brain lower grade glioma |
0.032547878 |
Sensitive |
| ENSG00000233016.2 |
Methotrexate |
Brain lower grade glioma |
0.039640782 |
Sensitive |
| ENSG00000233061.1 |
Methotrexate |
Brain lower grade glioma |
0.02341759 |
Sensitive |
| ENSG00000233922.1 |
Methotrexate |
Brain lower grade glioma |
0.025884732 |
Sensitive |
| ENSG00000233937.2 |
Methotrexate |
Brain lower grade glioma |
0.008402053 |
Sensitive |
| ENSG00000234072.1 |
Methotrexate |
Brain lower grade glioma |
0.041421444 |
Sensitive |
| ENSG00000234134.1 |
Methotrexate |
Brain lower grade glioma |
0.034076317 |
Sensitive |
| ENSG00000234141.1 |
Methotrexate |
Brain lower grade glioma |
0.014972952 |
Sensitive |
| ENSG00000234171.1 |
Methotrexate |
Brain lower grade glioma |
0.025412985 |
Sensitive |
| ENSG00000234183.1 |
Methotrexate |
Brain lower grade glioma |
0.016769644 |
Sensitive |
| ENSG00000234185.2 |
Methotrexate |
Brain lower grade glioma |
0.008621199 |
Sensitive |
| ENSG00000234263.1 |
Methotrexate |
Brain lower grade glioma |
0.036726338 |
Sensitive |
| ENSG00000234281.1 |
Methotrexate |
Brain lower grade glioma |
0.048720659 |
Sensitive |
| ENSG00000234509.1 |
Methotrexate |
Brain lower grade glioma |
0.03143621 |
Sensitive |
| ENSG00000234690.2 |
Methotrexate |
Brain lower grade glioma |
0.047014834 |
Sensitive |
| ENSG00000234741.3 |
Methotrexate |
Brain lower grade glioma |
0.009034031 |
Sensitive |
| ENSG00000234753.1 |
Methotrexate |
Brain lower grade glioma |
0.035099206 |
Sensitive |
| ENSG00000234771.2 |
Methotrexate |
Brain lower grade glioma |
0.014718388 |
Sensitive |
| ENSG00000234912.5 |
Methotrexate |
Brain lower grade glioma |
0.020599196 |
Sensitive |
| ENSG00000234917.1 |
Methotrexate |
Brain lower grade glioma |
0.013710456 |
Sensitive |
| ENSG00000234936.1 |
Methotrexate |
Brain lower grade glioma |
0.039987609 |
Sensitive |
| ENSG00000234943.2 |
Methotrexate |
Brain lower grade glioma |
0.046988059 |
Sensitive |
| ENSG00000234978.1 |
Methotrexate |
Brain lower grade glioma |
0.027314653 |
Sensitive |
| ENSG00000235381.1 |
Methotrexate |
Brain lower grade glioma |
0.016738741 |
Sensitive |
| ENSG00000235659.1 |
Methotrexate |
Brain lower grade glioma |
0.041575351 |
Sensitive |
| ENSG00000235904.1 |
Methotrexate |
Brain lower grade glioma |
0.041111613 |
Sensitive |
| ENSG00000235919.3 |
Methotrexate |
Brain lower grade glioma |
0.034534719 |
Sensitive |
| ENSG00000235954.2 |
Methotrexate |
Brain lower grade glioma |
0.001994411 |
Sensitive |
| ENSG00000236088.5 |
Methotrexate |
Brain lower grade glioma |
0.027563307 |
Sensitive |
| ENSG00000236144.2 |
Methotrexate |
Brain lower grade glioma |
0.03476462 |
Sensitive |
| ENSG00000236308.1 |
Methotrexate |
Brain lower grade glioma |
0.030967071 |
Sensitive |
| ENSG00000236438.2 |
Methotrexate |
Brain lower grade glioma |
0.046244618 |
Sensitive |
| ENSG00000236519.1 |
Methotrexate |
Brain lower grade glioma |
0.018148037 |
Sensitive |
| ENSG00000236671.3 |
Methotrexate |
Brain lower grade glioma |
0.013299962 |
Sensitive |
| ENSG00000236859.2 |
Methotrexate |
Brain lower grade glioma |
0.021216944 |
Sensitive |
| ENSG00000237291.2 |
Methotrexate |
Brain lower grade glioma |
0.008693927 |
Sensitive |
| ENSG00000237410.1 |
Methotrexate |
Brain lower grade glioma |
0.025521217 |
Sensitive |
| ENSG00000237877.2 |
Methotrexate |
Brain lower grade glioma |
0.044480294 |
Sensitive |
| ENSG00000238009.2 |
Methotrexate |
Brain lower grade glioma |
0.022685553 |
Sensitive |
| ENSG00000238035.4 |
Methotrexate |
Brain lower grade glioma |
0.027050152 |
Sensitive |
| ENSG00000238113.2 |
Methotrexate |
Brain lower grade glioma |
0.044364886 |
Sensitive |
| ENSG00000238197.1 |
Methotrexate |
Brain lower grade glioma |
0.040453685 |
Sensitive |
| ENSG00000238261.5 |
Methotrexate |
Brain lower grade glioma |
0.018035976 |
Sensitive |
| ENSG00000239415.1 |
Methotrexate |
Brain lower grade glioma |
0.043596533 |
Sensitive |
| ENSG00000239480.1 |
Methotrexate |
Brain lower grade glioma |
0.035927942 |
Sensitive |
| ENSG00000239569.2 |
Methotrexate |
Brain lower grade glioma |
0.025713874 |
Sensitive |
| ENSG00000239906.1 |
Methotrexate |
Brain lower grade glioma |
0.036231258 |
Sensitive |
| ENSG00000239945.1 |
Methotrexate |
Brain lower grade glioma |
0.033581924 |
Sensitive |
| ENSG00000240449.1 |
Methotrexate |
Brain lower grade glioma |
0.037427121 |
Sensitive |
| ENSG00000240567.1 |
Methotrexate |
Brain lower grade glioma |
0.01097043 |
Sensitive |
| ENSG00000240996.1 |
Methotrexate |
Brain lower grade glioma |
0.023393331 |
Sensitive |
| ENSG00000241155.1 |
Methotrexate |
Brain lower grade glioma |
0.039371125 |
Sensitive |
| ENSG00000241764.3 |
Methotrexate |
Brain lower grade glioma |
0.036506824 |
Sensitive |
| ENSG00000242082.1 |
Methotrexate |
Brain lower grade glioma |
0.0367959 |
Sensitive |
| ENSG00000242474.1 |
Methotrexate |
Brain lower grade glioma |
0.048284658 |
Sensitive |
| ENSG00000243224.1 |
Methotrexate |
Brain lower grade glioma |
0.041845679 |
Sensitive |
| ENSG00000243926.1 |
Methotrexate |
Brain lower grade glioma |
0.017984195 |
Sensitive |
| ENSG00000243960.1 |
Methotrexate |
Brain lower grade glioma |
0.030583391 |
Sensitive |
| ENSG00000244733.4 |
Methotrexate |
Brain lower grade glioma |
0.021161168 |
Sensitive |
| ENSG00000244968.2 |
Methotrexate |
Brain lower grade glioma |
0.034234868 |
Sensitive |
| ENSG00000245213.2 |
Methotrexate |
Brain lower grade glioma |
0.01128011 |
Sensitive |
| ENSG00000245248.3 |
Methotrexate |
Brain lower grade glioma |
0.042571898 |
Sensitive |
| ENSG00000245534.2 |
Methotrexate |
Brain lower grade glioma |
0.015388009 |
Sensitive |
| ENSG00000246263.2 |
Methotrexate |
Brain lower grade glioma |
0.046480191 |
Sensitive |
| ENSG00000246334.2 |
Methotrexate |
Brain lower grade glioma |
0.01965764 |
Sensitive |
| ENSG00000246763.2 |
Methotrexate |
Brain lower grade glioma |
0.008591888 |
Sensitive |
| ENSG00000246889.2 |
Methotrexate |
Brain lower grade glioma |
0.033126108 |
Sensitive |
| ENSG00000246985.3 |
Methotrexate |
Brain lower grade glioma |
0.029986978 |
Sensitive |
| ENSG00000247134.2 |
Methotrexate |
Brain lower grade glioma |
0.032151226 |
Sensitive |
| ENSG00000247363.2 |
Methotrexate |
Brain lower grade glioma |
0.012845403 |
Sensitive |
| ENSG00000247373.2 |
Methotrexate |
Brain lower grade glioma |
0.013233059 |
Sensitive |
| ENSG00000247595.2 |
Methotrexate |
Brain lower grade glioma |
0.038683601 |
Sensitive |
| ENSG00000247675.2 |
Methotrexate |
Brain lower grade glioma |
0.006761705 |
Sensitive |
| ENSG00000247708.3 |
Methotrexate |
Brain lower grade glioma |
0.016721855 |
Sensitive |
| ENSG00000247877.2 |
Methotrexate |
Brain lower grade glioma |
0.026450262 |
Sensitive |
| ENSG00000248103.1 |
Methotrexate |
Brain lower grade glioma |
0.03828486 |
Sensitive |
| ENSG00000248367.1 |
Methotrexate |
Brain lower grade glioma |
0.009605447 |
Sensitive |
| ENSG00000248508.2 |
Methotrexate |
Brain lower grade glioma |
0.030855279 |
Sensitive |
| ENSG00000248559.1 |
Methotrexate |
Brain lower grade glioma |
0.044446246 |
Sensitive |
| ENSG00000248740.1 |
Methotrexate |
Brain lower grade glioma |
0.021141883 |
Sensitive |
| ENSG00000248932.1 |
Methotrexate |
Brain lower grade glioma |
0.010004879 |
Sensitive |
| ENSG00000249572.1 |
Methotrexate |
Brain lower grade glioma |
0.029971028 |
Sensitive |
| ENSG00000249592.1 |
Methotrexate |
Brain lower grade glioma |
0.004290092 |
Sensitive |
| ENSG00000249602.1 |
Methotrexate |
Brain lower grade glioma |
0.019769778 |
Sensitive |
| ENSG00000249673.2 |
Methotrexate |
Brain lower grade glioma |
0.012711818 |
Sensitive |
| ENSG00000249753.2 |
Methotrexate |
Brain lower grade glioma |
0.023128029 |
Sensitive |
| ENSG00000249791.1 |
Methotrexate |
Brain lower grade glioma |
0.044824225 |
Sensitive |
| ENSG00000249859.3 |
Methotrexate |
Brain lower grade glioma |
0.009091941 |
Sensitive |
| ENSG00000250107.1 |
Methotrexate |
Brain lower grade glioma |
0.029871084 |
Sensitive |
| ENSG00000250208.2 |
Methotrexate |
Brain lower grade glioma |
0.042716674 |
Sensitive |
| ENSG00000250337.1 |
Methotrexate |
Brain lower grade glioma |
0.045624164 |
Sensitive |
| ENSG00000250343.1 |
Methotrexate |
Brain lower grade glioma |
0.037988755 |
Sensitive |
| ENSG00000250365.2 |
Methotrexate |
Brain lower grade glioma |
0.035544814 |
Sensitive |
| ENSG00000250899.3 |
Methotrexate |
Brain lower grade glioma |
0.006160271 |
Sensitive |
| ENSG00000251175.1 |
Methotrexate |
Brain lower grade glioma |
0.037188635 |
Sensitive |
| ENSG00000251323.2 |
Methotrexate |
Brain lower grade glioma |
0.0347412 |
Sensitive |
| ENSG00000251666.1 |
Methotrexate |
Brain lower grade glioma |
0.031239759 |
Sensitive |
| ENSG00000253106.1 |
Methotrexate |
Brain lower grade glioma |
0.044788277 |
Sensitive |
| ENSG00000253307.1 |
Methotrexate |
Brain lower grade glioma |
0.035659123 |
Sensitive |
| ENSG00000253917.3 |
Methotrexate |
Brain lower grade glioma |
0.031572069 |
Sensitive |
| ENSG00000253921.1 |
Methotrexate |
Brain lower grade glioma |
0.020015455 |
Sensitive |
| ENSG00000254042.1 |
Methotrexate |
Brain lower grade glioma |
0.046933965 |
Sensitive |
| ENSG00000254353.1 |
Methotrexate |
Brain lower grade glioma |
0.014895304 |
Sensitive |
| ENSG00000254682.1 |
Methotrexate |
Brain lower grade glioma |
0.026986264 |
Sensitive |
| ENSG00000254929.2 |
Methotrexate |
Brain lower grade glioma |
0.006248359 |
Sensitive |
| ENSG00000255050.1 |
Methotrexate |
Brain lower grade glioma |
0.030457049 |
Sensitive |
| ENSG00000255129.1 |
Methotrexate |
Brain lower grade glioma |
0.025769622 |
Sensitive |
| ENSG00000255135.3 |
Methotrexate |
Brain lower grade glioma |
0.039262242 |
Sensitive |
| ENSG00000255409.1 |
Methotrexate |
Brain lower grade glioma |
0.04576236 |
Sensitive |
| ENSG00000255449.1 |
Methotrexate |
Brain lower grade glioma |
0.003824422 |
Sensitive |
| ENSG00000255458.1 |
Methotrexate |
Brain lower grade glioma |
0.011039609 |
Sensitive |
| ENSG00000255717.2 |
Methotrexate |
Brain lower grade glioma |
0.043428283 |
Sensitive |
| ENSG00000255857.1 |
Methotrexate |
Brain lower grade glioma |
0.009986593 |
Sensitive |
| ENSG00000256092.2 |
Methotrexate |
Brain lower grade glioma |
0.01733374 |
Sensitive |
| ENSG00000256196.1 |
Methotrexate |
Brain lower grade glioma |
0.048861056 |
Sensitive |
| ENSG00000256458.1 |
Methotrexate |
Brain lower grade glioma |
0.020867665 |
Sensitive |
| ENSG00000257023.1 |
Methotrexate |
Brain lower grade glioma |
0.035779418 |
Sensitive |
| ENSG00000257543.1 |
Methotrexate |
Brain lower grade glioma |
0.01871619 |
Sensitive |
| ENSG00000257596.1 |
Methotrexate |
Brain lower grade glioma |
0.022843171 |
Sensitive |
| ENSG00000257605.1 |
Methotrexate |
Brain lower grade glioma |
0.016053855 |
Sensitive |
| ENSG00000257698.1 |
Methotrexate |
Brain lower grade glioma |
0.030392154 |
Sensitive |
| ENSG00000257815.1 |
Methotrexate |
Brain lower grade glioma |
0.039858908 |
Sensitive |
| ENSG00000257913.1 |
Methotrexate |
Brain lower grade glioma |
0.039889425 |
Sensitive |
| ENSG00000258001.1 |
Methotrexate |
Brain lower grade glioma |
0.044816087 |
Sensitive |
| ENSG00000258057.1 |
Methotrexate |
Brain lower grade glioma |
0.028425992 |
Sensitive |
| ENSG00000258199.1 |
Methotrexate |
Brain lower grade glioma |
0.032432068 |
Sensitive |
| ENSG00000258344.1 |
Methotrexate |
Brain lower grade glioma |
0.034011181 |
Sensitive |
| ENSG00000258354.1 |
Methotrexate |
Brain lower grade glioma |
0.015656085 |
Sensitive |
| ENSG00000258789.1 |
Methotrexate |
Brain lower grade glioma |
0.038892376 |
Sensitive |
| ENSG00000259129.1 |
Methotrexate |
Brain lower grade glioma |
0.043702806 |
Sensitive |
| ENSG00000259187.1 |
Methotrexate |
Brain lower grade glioma |
0.028814315 |
Sensitive |
| ENSG00000259209.1 |
Methotrexate |
Brain lower grade glioma |
0.024596712 |
Sensitive |
| ENSG00000259251.2 |
Methotrexate |
Brain lower grade glioma |
0.013244993 |
Sensitive |
| ENSG00000259416.2 |
Methotrexate |
Brain lower grade glioma |
0.041952657 |
Sensitive |
| ENSG00000259424.1 |
Methotrexate |
Brain lower grade glioma |
0.018654377 |
Sensitive |
| ENSG00000259442.1 |
Methotrexate |
Brain lower grade glioma |
0.007052388 |
Sensitive |
| ENSG00000259595.1 |
Methotrexate |
Brain lower grade glioma |
0.02812339 |
Sensitive |
| ENSG00000259744.1 |
Methotrexate |
Brain lower grade glioma |
0.017955015 |
Sensitive |
| ENSG00000259762.1 |
Methotrexate |
Brain lower grade glioma |
0.017120328 |
Sensitive |
| ENSG00000259802.1 |
Methotrexate |
Brain lower grade glioma |
0.025497873 |
Sensitive |
| ENSG00000259806.2 |
Methotrexate |
Brain lower grade glioma |
0.04039958 |
Sensitive |
| ENSG00000259877.1 |
Methotrexate |
Brain lower grade glioma |
0.036959813 |
Sensitive |
| ENSG00000259959.1 |
Methotrexate |
Brain lower grade glioma |
0.006925136 |
Sensitive |
| ENSG00000259994.1 |
Methotrexate |
Brain lower grade glioma |
0.004279741 |
Sensitive |
| ENSG00000260006.1 |
Methotrexate |
Brain lower grade glioma |
0.039976764 |
Sensitive |
| ENSG00000260037.1 |
Methotrexate |
Brain lower grade glioma |
0.016200014 |
Sensitive |
| ENSG00000260233.2 |
Methotrexate |
Brain lower grade glioma |
0.014582865 |
Sensitive |
| ENSG00000260261.1 |
Methotrexate |
Brain lower grade glioma |
0.010517264 |
Sensitive |
| ENSG00000260296.1 |
Methotrexate |
Brain lower grade glioma |
0.034645454 |
Sensitive |
| ENSG00000260388.1 |
Methotrexate |
Brain lower grade glioma |
0.023630909 |
Sensitive |
| ENSG00000260394.2 |
Methotrexate |
Brain lower grade glioma |
0.033451797 |
Sensitive |
| ENSG00000260425.1 |
Methotrexate |
Brain lower grade glioma |
0.022887513 |
Sensitive |
| ENSG00000260464.1 |
Methotrexate |
Brain lower grade glioma |
0.020736473 |
Sensitive |
| ENSG00000260526.1 |
Methotrexate |
Brain lower grade glioma |
0.019272377 |
Sensitive |
| ENSG00000260583.1 |
Methotrexate |
Brain lower grade glioma |
0.016361033 |
Sensitive |
| ENSG00000260589.1 |
Methotrexate |
Brain lower grade glioma |
0.037513832 |
Sensitive |
| ENSG00000260626.1 |
Methotrexate |
Brain lower grade glioma |
0.048245583 |
Sensitive |
| ENSG00000260646.1 |
Methotrexate |
Brain lower grade glioma |
0.048642686 |
Sensitive |
| ENSG00000260766.1 |
Methotrexate |
Brain lower grade glioma |
0.037229512 |
Sensitive |
| ENSG00000260917.1 |
Methotrexate |
Brain lower grade glioma |
0.019483145 |
Sensitive |
| ENSG00000260942.1 |
Methotrexate |
Brain lower grade glioma |
0.017476332 |
Sensitive |
| ENSG00000260948.1 |
Methotrexate |
Brain lower grade glioma |
0.025498246 |
Sensitive |
| ENSG00000260988.1 |
Methotrexate |
Brain lower grade glioma |
0.047792008 |
Sensitive |
| ENSG00000261008.2 |
Methotrexate |
Brain lower grade glioma |
0.02958816 |
Sensitive |
| ENSG00000261096.1 |
Methotrexate |
Brain lower grade glioma |
0.026405076 |
Sensitive |
| ENSG00000261124.1 |
Methotrexate |
Brain lower grade glioma |
0.030130488 |
Sensitive |
| ENSG00000261135.1 |
Methotrexate |
Brain lower grade glioma |
0.014944411 |
Sensitive |
| ENSG00000261173.1 |
Methotrexate |
Brain lower grade glioma |
0.004823503 |
Sensitive |
| ENSG00000261188.1 |
Methotrexate |
Brain lower grade glioma |
0.0233364 |
Sensitive |
| ENSG00000261251.1 |
Methotrexate |
Brain lower grade glioma |
0.039957569 |
Sensitive |
| ENSG00000261254.1 |
Methotrexate |
Brain lower grade glioma |
0.046725253 |
Sensitive |
| ENSG00000261441.1 |
Methotrexate |
Brain lower grade glioma |
0.027943837 |
Sensitive |
| ENSG00000261474.1 |
Methotrexate |
Brain lower grade glioma |
0.029198705 |
Sensitive |
| ENSG00000261560.1 |
Methotrexate |
Brain lower grade glioma |
0.040877013 |
Sensitive |
| ENSG00000261582.1 |
Methotrexate |
Brain lower grade glioma |
0.029707272 |
Sensitive |
| ENSG00000261589.1 |
Methotrexate |
Brain lower grade glioma |
0.033780111 |
Sensitive |
| ENSG00000261592.1 |
Methotrexate |
Brain lower grade glioma |
0.033953357 |
Sensitive |
| ENSG00000261663.1 |
Methotrexate |
Brain lower grade glioma |
0.047915217 |
Sensitive |
| ENSG00000261775.1 |
Methotrexate |
Brain lower grade glioma |
0.020741268 |
Sensitive |
| ENSG00000261777.1 |
Methotrexate |
Brain lower grade glioma |
0.023373654 |
Sensitive |
| ENSG00000262194.1 |
Methotrexate |
Brain lower grade glioma |
0.043906334 |
Sensitive |
| ENSG00000262222.1 |
Methotrexate |
Brain lower grade glioma |
0.045538737 |
Sensitive |
| ENSG00000262703.1 |
Methotrexate |
Brain lower grade glioma |
0.02387718 |
Sensitive |
| ENSG00000262766.1 |
Methotrexate |
Brain lower grade glioma |
0.049943577 |
Sensitive |
| ENSG00000262879.1 |
Methotrexate |
Brain lower grade glioma |
0.038089406 |
Sensitive |
| ENSG00000263050.1 |
Methotrexate |
Brain lower grade glioma |
0.017649876 |
Sensitive |
| ENSG00000263072.1 |
Methotrexate |
Brain lower grade glioma |
0.032809029 |
Sensitive |
| ENSG00000263214.1 |
Methotrexate |
Brain lower grade glioma |
0.008623705 |
Sensitive |
| ENSG00000263280.1 |
Methotrexate |
Brain lower grade glioma |
0.045607086 |
Sensitive |
| ENSG00000263350.1 |
Methotrexate |
Brain lower grade glioma |
0.046227817 |
Sensitive |
| ENSG00000263412.1 |
Methotrexate |
Brain lower grade glioma |
0.019406468 |
Sensitive |
| ENSG00000263531.1 |
Methotrexate |
Brain lower grade glioma |
0.013229307 |
Sensitive |
| ENSG00000263727.1 |
Methotrexate |
Brain lower grade glioma |
0.032711338 |
Sensitive |
| ENSG00000263731.1 |
Methotrexate |
Brain lower grade glioma |
0.043332481 |
Sensitive |
| ENSG00000263786.1 |
Methotrexate |
Brain lower grade glioma |
0.030608875 |
Sensitive |
| ENSG00000263859.1 |
Methotrexate |
Brain lower grade glioma |
0.040831046 |
Sensitive |
| ENSG00000263884.1 |
Methotrexate |
Brain lower grade glioma |
0.016995174 |
Sensitive |
| ENSG00000264207.1 |
Methotrexate |
Brain lower grade glioma |
0.041680862 |
Sensitive |
| ENSG00000264520.1 |
Methotrexate |
Brain lower grade glioma |
0.005775003 |
Sensitive |
| ENSG00000264548.1 |
Methotrexate |
Brain lower grade glioma |
0.04088583 |
Sensitive |
| ENSG00000265242.1 |
Methotrexate |
Brain lower grade glioma |
0.021077144 |
Sensitive |
| ENSG00000265334.1 |
Methotrexate |
Brain lower grade glioma |
0.017129719 |
Sensitive |
| ENSG00000265443.1 |
Methotrexate |
Brain lower grade glioma |
0.018486924 |
Sensitive |
| ENSG00000265692.1 |
Methotrexate |
Brain lower grade glioma |
0.015499919 |
Sensitive |
| ENSG00000265778.1 |
Methotrexate |
Brain lower grade glioma |
0.034467004 |
Sensitive |
| ENSG00000265800.1 |
Methotrexate |
Brain lower grade glioma |
0.027912578 |
Sensitive |
| ENSG00000266402.2 |
Methotrexate |
Brain lower grade glioma |
0.021468908 |
Sensitive |
| ENSG00000266456.1 |
Methotrexate |
Brain lower grade glioma |
0.016421786 |
Sensitive |
| ENSG00000266473.1 |
Methotrexate |
Brain lower grade glioma |
0.028721508 |
Sensitive |
| ENSG00000266904.1 |
Methotrexate |
Brain lower grade glioma |
0.014148502 |
Sensitive |
| ENSG00000267002.1 |
Methotrexate |
Brain lower grade glioma |
0.036970573 |
Sensitive |
| ENSG00000267003.1 |
Methotrexate |
Brain lower grade glioma |
0.027651207 |
Sensitive |
| ENSG00000267018.1 |
Methotrexate |
Brain lower grade glioma |
0.021654565 |
Sensitive |
| ENSG00000267040.2 |
Methotrexate |
Brain lower grade glioma |
0.016928321 |
Sensitive |
| ENSG00000267108.1 |
Methotrexate |
Brain lower grade glioma |
0.029246923 |
Sensitive |
| ENSG00000267199.1 |
Methotrexate |
Brain lower grade glioma |
0.015400731 |
Sensitive |
| ENSG00000267207.1 |
Methotrexate |
Brain lower grade glioma |
0.002301349 |
Sensitive |
| ENSG00000267265.1 |
Methotrexate |
Brain lower grade glioma |
0.035358561 |
Sensitive |
| ENSG00000267419.1 |
Methotrexate |
Brain lower grade glioma |
0.020632593 |
Sensitive |
| ENSG00000267449.1 |
Methotrexate |
Brain lower grade glioma |
0.011482094 |
Sensitive |
| ENSG00000267481.1 |
Methotrexate |
Brain lower grade glioma |
0.032209378 |
Sensitive |
| ENSG00000267581.1 |
Methotrexate |
Brain lower grade glioma |
0.035785907 |
Sensitive |
| ENSG00000267655.1 |
Methotrexate |
Brain lower grade glioma |
0.036618543 |
Sensitive |
| ENSG00000267672.1 |
Methotrexate |
Brain lower grade glioma |
0.038051981 |
Sensitive |
| ENSG00000267778.1 |
Methotrexate |
Brain lower grade glioma |
0.047413658 |
Sensitive |
| ENSG00000267787.1 |
Methotrexate |
Brain lower grade glioma |
0.03124672 |
Sensitive |
| ENSG00000267834.1 |
Methotrexate |
Brain lower grade glioma |
0.046879021 |
Sensitive |
| ENSG00000267871.1 |
Methotrexate |
Brain lower grade glioma |
0.007487983 |
Sensitive |
| ENSG00000267940.1 |
Methotrexate |
Brain lower grade glioma |
0.038164005 |
Sensitive |
| ENSG00000268047.1 |
Methotrexate |
Brain lower grade glioma |
0.036377751 |
Sensitive |
| ENSG00000268199.2 |
Methotrexate |
Brain lower grade glioma |
0.023891461 |
Sensitive |
| ENSG00000268889.1 |
Methotrexate |
Brain lower grade glioma |
0.008511489 |
Sensitive |
| ENSG00000269038.1 |
Methotrexate |
Brain lower grade glioma |
0.01133433 |
Sensitive |
| ENSG00000269091.1 |
Methotrexate |
Brain lower grade glioma |
0.040441308 |
Sensitive |
| ENSG00000269290.1 |
Methotrexate |
Brain lower grade glioma |
0.001236466 |
Sensitive |
| ENSG00000269386.1 |
Methotrexate |
Brain lower grade glioma |
0.035363103 |
Sensitive |
| ENSG00000269473.1 |
Methotrexate |
Brain lower grade glioma |
0.027022867 |
Sensitive |
| ENSG00000269535.1 |
Methotrexate |
Brain lower grade glioma |
0.012534563 |
Sensitive |
| ENSG00000269574.1 |
Methotrexate |
Brain lower grade glioma |
0.018677556 |
Sensitive |
| ENSG00000269609.1 |
Methotrexate |
Brain lower grade glioma |
0.023564692 |
Sensitive |
| ENSG00000269815.1 |
Methotrexate |
Brain lower grade glioma |
0.014910784 |
Sensitive |
| ENSG00000269893.2 |
Methotrexate |
Brain lower grade glioma |
0.031622834 |
Sensitive |
| ENSG00000269938.1 |
Methotrexate |
Brain lower grade glioma |
0.021442188 |
Sensitive |
| ENSG00000269947.1 |
Methotrexate |
Brain lower grade glioma |
0.041108623 |
Sensitive |
| ENSG00000269990.1 |
Methotrexate |
Brain lower grade glioma |
0.047083706 |
Sensitive |
| ENSG00000269997.1 |
Methotrexate |
Brain lower grade glioma |
0.019852401 |
Sensitive |
| ENSG00000270048.1 |
Methotrexate |
Brain lower grade glioma |
0.039251922 |
Sensitive |
| ENSG00000270049.1 |
Methotrexate |
Brain lower grade glioma |
0.014688295 |
Sensitive |
| ENSG00000270061.1 |
Methotrexate |
Brain lower grade glioma |
0.017437649 |
Sensitive |
| ENSG00000270068.1 |
Methotrexate |
Brain lower grade glioma |
0.014959632 |
Sensitive |
| ENSG00000270084.1 |
Methotrexate |
Brain lower grade glioma |
0.00900244 |
Sensitive |
| ENSG00000270095.1 |
Methotrexate |
Brain lower grade glioma |
0.011029406 |
Sensitive |
| ENSG00000270102.1 |
Methotrexate |
Brain lower grade glioma |
0.032875447 |
Sensitive |
| ENSG00000270109.1 |
Methotrexate |
Brain lower grade glioma |
0.01890496 |
Sensitive |
| ENSG00000270130.1 |
Methotrexate |
Brain lower grade glioma |
0.035401656 |
Sensitive |
| ENSG00000270332.1 |
Methotrexate |
Brain lower grade glioma |
0.01760027 |
Sensitive |
| ENSG00000270605.1 |
Methotrexate |
Brain lower grade glioma |
0.024913136 |
Sensitive |
| ENSG00000271199.1 |
Methotrexate |
Brain lower grade glioma |
0.03740156 |
Sensitive |
| ENSG00000271270.1 |
Methotrexate |
Brain lower grade glioma |
0.023926429 |
Sensitive |
| ENSG00000271335.1 |
Methotrexate |
Brain lower grade glioma |
0.004139102 |
Sensitive |
| ENSG00000271738.1 |
Methotrexate |
Brain lower grade glioma |
0.019064958 |
Sensitive |
| ENSG00000271815.1 |
Methotrexate |
Brain lower grade glioma |
0.02043427 |
Sensitive |
| ENSG00000271855.1 |
Methotrexate |
Brain lower grade glioma |
0.020672035 |
Sensitive |
| ENSG00000271963.1 |
Methotrexate |
Brain lower grade glioma |
0.040365934 |
Sensitive |
| ENSG00000271964.1 |
Methotrexate |
Brain lower grade glioma |
0.024801582 |
Sensitive |
| ENSG00000271971.1 |
Methotrexate |
Brain lower grade glioma |
0.044001925 |
Sensitive |
| ENSG00000271983.1 |
Methotrexate |
Brain lower grade glioma |
0.023263817 |
Sensitive |
| ENSG00000271996.1 |
Methotrexate |
Brain lower grade glioma |
0.037159494 |
Sensitive |
| ENSG00000271997.1 |
Methotrexate |
Brain lower grade glioma |
0.0426162 |
Sensitive |
| ENSG00000272004.1 |
Methotrexate |
Brain lower grade glioma |
0.033161885 |
Sensitive |
| ENSG00000272068.1 |
Methotrexate |
Brain lower grade glioma |
0.025699592 |
Sensitive |
| ENSG00000272143.1 |
Methotrexate |
Brain lower grade glioma |
0.043951911 |
Sensitive |
| ENSG00000272156.1 |
Methotrexate |
Brain lower grade glioma |
0.023163173 |
Sensitive |
| ENSG00000272216.1 |
Methotrexate |
Brain lower grade glioma |
0.031730198 |
Sensitive |
| ENSG00000272335.1 |
Methotrexate |
Brain lower grade glioma |
0.037095887 |
Sensitive |
| ENSG00000272365.1 |
Methotrexate |
Brain lower grade glioma |
0.035579061 |
Sensitive |
| ENSG00000272373.1 |
Methotrexate |
Brain lower grade glioma |
0.017830726 |
Sensitive |
| ENSG00000272417.1 |
Methotrexate |
Brain lower grade glioma |
0.031519083 |
Sensitive |
| ENSG00000272508.1 |
Methotrexate |
Brain lower grade glioma |
0.022683748 |
Sensitive |
| ENSG00000272518.1 |
Methotrexate |
Brain lower grade glioma |
0.013372328 |
Sensitive |
| ENSG00000272525.1 |
Methotrexate |
Brain lower grade glioma |
0.038545502 |
Sensitive |
| ENSG00000272635.1 |
Methotrexate |
Brain lower grade glioma |
0.024264088 |
Sensitive |
| ENSG00000272644.1 |
Methotrexate |
Brain lower grade glioma |
0.044632412 |
Sensitive |
| ENSG00000272699.1 |
Methotrexate |
Brain lower grade glioma |
0.030272048 |
Sensitive |
| ENSG00000272707.1 |
Methotrexate |
Brain lower grade glioma |
0.000282969 |
Sensitive |
| ENSG00000272716.1 |
Methotrexate |
Brain lower grade glioma |
0.022825654 |
Sensitive |
| ENSG00000272744.1 |
Methotrexate |
Brain lower grade glioma |
0.003334772 |
Sensitive |
| ENSG00000272777.1 |
Methotrexate |
Brain lower grade glioma |
0.009230269 |
Sensitive |
| ENSG00000272828.1 |
Methotrexate |
Brain lower grade glioma |
0.024054111 |
Sensitive |
| ENSG00000272836.1 |
Methotrexate |
Brain lower grade glioma |
0.036496566 |
Sensitive |
| ENSG00000272853.1 |
Methotrexate |
Brain lower grade glioma |
0.049001017 |
Sensitive |
| ENSG00000272885.1 |
Methotrexate |
Brain lower grade glioma |
0.022929368 |
Sensitive |
| ENSG00000272892.1 |
Methotrexate |
Brain lower grade glioma |
0.032086892 |
Sensitive |
| ENSG00000273011.1 |
Methotrexate |
Brain lower grade glioma |
0.035205977 |
Sensitive |
| ENSG00000273014.1 |
Methotrexate |
Brain lower grade glioma |
0.034932773 |
Sensitive |
| ENSG00000273061.1 |
Methotrexate |
Brain lower grade glioma |
0.049565065 |
Sensitive |
| ENSG00000273133.1 |
Methotrexate |
Brain lower grade glioma |
0.016255714 |
Sensitive |
| ENSG00000273165.1 |
Methotrexate |
Brain lower grade glioma |
0.049848194 |
Sensitive |
| ENSG00000273188.1 |
Methotrexate |
Brain lower grade glioma |
0.027793041 |
Sensitive |
| ENSG00000273245.1 |
Methotrexate |
Brain lower grade glioma |
0.018703009 |
Sensitive |
| ENSG00000273265.1 |
Methotrexate |
Brain lower grade glioma |
0.030188176 |
Sensitive |
| ENSG00000273290.1 |
Methotrexate |
Brain lower grade glioma |
0.042749678 |
Sensitive |
| ENSG00000273306.1 |
Methotrexate |
Brain lower grade glioma |
0.045213054 |
Sensitive |
| ENSG00000273329.1 |
Methotrexate |
Brain lower grade glioma |
0.040043312 |
Sensitive |
| ENSG00000273343.1 |
Methotrexate |
Brain lower grade glioma |
0.023860546 |
Sensitive |
| ENSG00000273374.1 |
Methotrexate |
Brain lower grade glioma |
0.029067873 |
Sensitive |
| ENSG00000273449.1 |
Methotrexate |
Brain lower grade glioma |
0.010774536 |
Sensitive |
| ENSG00000273488.1 |
Methotrexate |
Brain lower grade glioma |
0.045208129 |
Sensitive |
| ENSG00000172250.10 |
Methotrexate |
Liver hepatocellular carcinoma |
0.014029651 |
Sensitive |
| ENSG00000215241.3 |
Methotrexate |
Liver hepatocellular carcinoma |
0.017264334 |
Sensitive |
| ENSG00000215424.5 |
Methotrexate |
Liver hepatocellular carcinoma |
0.026701757 |
Sensitive |
| ENSG00000223799.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.024473892 |
Sensitive |
| ENSG00000225213.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.013609034 |
Sensitive |
| ENSG00000225411.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.009834815 |
Sensitive |
| ENSG00000227698.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.018254464 |
Sensitive |
| ENSG00000227719.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.008107109 |
Sensitive |
| ENSG00000229980.4 |
Methotrexate |
Liver hepatocellular carcinoma |
0.006911397 |
Sensitive |
| ENSG00000230699.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.030062009 |
Sensitive |
| ENSG00000231527.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.010020046 |
Sensitive |
| ENSG00000231999.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.011338991 |
Sensitive |
| ENSG00000232504.4 |
Methotrexate |
Liver hepatocellular carcinoma |
0.032556276 |
Sensitive |
| ENSG00000233033.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.016930699 |
Sensitive |
| ENSG00000233806.3 |
Methotrexate |
Liver hepatocellular carcinoma |
0.017819763 |
Sensitive |
| ENSG00000236166.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.034145657 |
Sensitive |
| ENSG00000237250.3 |
Methotrexate |
Liver hepatocellular carcinoma |
0.015439108 |
Sensitive |
| ENSG00000238197.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.025804325 |
Sensitive |
| ENSG00000240254.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.005898959 |
Sensitive |
| ENSG00000240571.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.039968008 |
Sensitive |
| ENSG00000241180.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.008370908 |
Sensitive |
| ENSG00000243885.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.013729226 |
Sensitive |
| ENSG00000244286.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.028155027 |
Sensitive |
| ENSG00000246263.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.002076837 |
Sensitive |
| ENSG00000248265.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.003927405 |
Sensitive |
| ENSG00000248932.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.042355302 |
Sensitive |
| ENSG00000253390.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.013835185 |
Sensitive |
| ENSG00000253720.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.026618545 |
Sensitive |
| ENSG00000253878.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.033587916 |
Sensitive |
| ENSG00000254353.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.02590581 |
Sensitive |
| ENSG00000254602.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.003570436 |
Sensitive |
| ENSG00000256325.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.042098734 |
Sensitive |
| ENSG00000256576.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.009557939 |
Sensitive |
| ENSG00000257285.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.035516393 |
Sensitive |
| ENSG00000257718.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.008576406 |
Sensitive |
| ENSG00000258199.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.009673235 |
Sensitive |
| ENSG00000259298.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.047558147 |
Sensitive |
| ENSG00000259345.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.022015458 |
Sensitive |
| ENSG00000259439.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.000105257 |
Sensitive |
| ENSG00000259659.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.048497058 |
Sensitive |
| ENSG00000260022.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.043703875 |
Sensitive |
| ENSG00000260193.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.030797253 |
Sensitive |
| ENSG00000260464.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.004780245 |
Sensitive |
| ENSG00000260948.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.040864798 |
Sensitive |
| ENSG00000261613.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.039546181 |
Sensitive |
| ENSG00000261824.2 |
Methotrexate |
Liver hepatocellular carcinoma |
0.004440094 |
Sensitive |
| ENSG00000263627.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.019514619 |
Sensitive |
| ENSG00000263924.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.046808123 |
Sensitive |
| ENSG00000264673.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.020121796 |
Sensitive |
| ENSG00000265688.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.005889712 |
Sensitive |
| ENSG00000265750.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.041495352 |
Sensitive |
| ENSG00000267272.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.004436772 |
Sensitive |
| ENSG00000268093.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.03778082 |
Sensitive |
| ENSG00000268751.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.019279728 |
Sensitive |
| ENSG00000271912.1 |
Methotrexate |
Liver hepatocellular carcinoma |
0.005299363 |
Sensitive |
| ENSG00000178412.4 |
Methotrexate |
Lung squamous cell carcinoma |
0.010957733 |
Sensitive |
| ENSG00000186019.10 |
Methotrexate |
Lung squamous cell carcinoma |
0.033378686 |
Sensitive |
| ENSG00000187621.10 |
Methotrexate |
Lung squamous cell carcinoma |
0.045587529 |
Sensitive |
| ENSG00000187904.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.019968246 |
Sensitive |
| ENSG00000215022.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.02166317 |
Sensitive |
| ENSG00000215417.6 |
Methotrexate |
Lung squamous cell carcinoma |
0.031306699 |
Sensitive |
| ENSG00000223379.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.046552775 |
Sensitive |
| ENSG00000223608.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.048977348 |
Sensitive |
| ENSG00000223665.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.048328079 |
Sensitive |
| ENSG00000224043.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.001722767 |
Sensitive |
| ENSG00000224384.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.01736491 |
Sensitive |
| ENSG00000225439.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.012163269 |
Sensitive |
| ENSG00000226113.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.008563598 |
Sensitive |
| ENSG00000226627.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.038410837 |
Sensitive |
| ENSG00000226899.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.014310811 |
Sensitive |
| ENSG00000226917.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.034176257 |
Sensitive |
| ENSG00000227165.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.028721054 |
Sensitive |
| ENSG00000227372.6 |
Methotrexate |
Lung squamous cell carcinoma |
0.002075895 |
Sensitive |
| ENSG00000227932.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.039033433 |
Sensitive |
| ENSG00000229531.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.028872507 |
Sensitive |
| ENSG00000229766.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.025416667 |
Sensitive |
| ENSG00000230735.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.025757948 |
Sensitive |
| ENSG00000230806.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.016119331 |
Sensitive |
| ENSG00000232677.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.03204272 |
Sensitive |
| ENSG00000233080.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.036674606 |
Sensitive |
| ENSG00000233906.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.039705178 |
Sensitive |
| ENSG00000234456.3 |
Methotrexate |
Lung squamous cell carcinoma |
0.02303973 |
Sensitive |
| ENSG00000234740.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.017450336 |
Sensitive |
| ENSG00000234915.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.009958096 |
Sensitive |
| ENSG00000236536.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.011287992 |
Sensitive |
| ENSG00000236558.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.032642351 |
Sensitive |
| ENSG00000236601.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.038160636 |
Sensitive |
| ENSG00000237179.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.037467501 |
Sensitive |
| ENSG00000237336.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.040564407 |
Sensitive |
| ENSG00000237937.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.022357675 |
Sensitive |
| ENSG00000239774.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.034296171 |
Sensitive |
| ENSG00000240549.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.009560672 |
Sensitive |
| ENSG00000242268.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.024872935 |
Sensitive |
| ENSG00000244203.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.042826582 |
Sensitive |
| ENSG00000244513.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.001637903 |
Sensitive |
| ENSG00000248266.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.005980942 |
Sensitive |
| ENSG00000248724.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.021784504 |
Sensitive |
| ENSG00000249028.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.02791867 |
Sensitive |
| ENSG00000250432.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.043397578 |
Sensitive |
| ENSG00000253335.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.045864155 |
Sensitive |
| ENSG00000253591.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.021815274 |
Sensitive |
| ENSG00000253603.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.002657972 |
Sensitive |
| ENSG00000253696.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.019190996 |
Sensitive |
| ENSG00000253764.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.014587721 |
Sensitive |
| ENSG00000254207.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.016452882 |
Sensitive |
| ENSG00000254369.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.042392745 |
Sensitive |
| ENSG00000254615.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.038524202 |
Sensitive |
| ENSG00000254653.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.006365038 |
Sensitive |
| ENSG00000254740.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.036655218 |
Sensitive |
| ENSG00000255129.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.009283965 |
Sensitive |
| ENSG00000255276.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.014101051 |
Sensitive |
| ENSG00000255542.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.046009675 |
Sensitive |
| ENSG00000256546.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.027700728 |
Sensitive |
| ENSG00000257910.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.01611442 |
Sensitive |
| ENSG00000259418.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.005238024 |
Sensitive |
| ENSG00000259488.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.024216985 |
Sensitive |
| ENSG00000260196.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.008653658 |
Sensitive |
| ENSG00000260289.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.041118364 |
Sensitive |
| ENSG00000260509.2 |
Methotrexate |
Lung squamous cell carcinoma |
0.027434524 |
Sensitive |
| ENSG00000261057.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.037793877 |
Sensitive |
| ENSG00000261204.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.040832027 |
Sensitive |
| ENSG00000263098.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.013640431 |
Sensitive |
| ENSG00000263388.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.038338689 |
Sensitive |
| ENSG00000264365.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.030177064 |
Sensitive |
| ENSG00000264647.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.046068772 |
Sensitive |
| ENSG00000264860.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.033867901 |
Sensitive |
| ENSG00000266466.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.00665586 |
Sensitive |
| ENSG00000266893.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.040451947 |
Sensitive |
| ENSG00000267251.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.004216038 |
Sensitive |
| ENSG00000267255.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.034251699 |
Sensitive |
| ENSG00000267381.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.018171816 |
Sensitive |
| ENSG00000267605.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.03571702 |
Sensitive |
| ENSG00000268289.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.021536151 |
Sensitive |
| ENSG00000269425.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.03585965 |
Sensitive |
| ENSG00000270109.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.000771718 |
Sensitive |
| ENSG00000270173.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.03858635 |
Sensitive |
| ENSG00000270237.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.036399032 |
Sensitive |
| ENSG00000270988.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.011921424 |
Sensitive |
| ENSG00000271894.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.034721473 |
Sensitive |
| ENSG00000271948.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.036992519 |
Sensitive |
| ENSG00000272004.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.018875747 |
Sensitive |
| ENSG00000272005.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.01911467 |
Sensitive |
| ENSG00000272077.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.01548883 |
Sensitive |
| ENSG00000272233.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.020327398 |
Sensitive |
| ENSG00000272379.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.038972884 |
Sensitive |
| ENSG00000272425.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.046513251 |
Sensitive |
| ENSG00000272452.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.0143007 |
Sensitive |
| ENSG00000272777.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.015089008 |
Sensitive |
| ENSG00000273004.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.026344137 |
Sensitive |
| ENSG00000273056.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.011437857 |
Sensitive |
| ENSG00000273428.1 |
Methotrexate |
Lung squamous cell carcinoma |
0.013173851 |
Sensitive |
| ENSG00000166770.6 |
Methotrexate |
Pancreatic adenocarcinoma |
0.027518899 |
Sensitive |
| ENSG00000223528.3 |
Methotrexate |
Pancreatic adenocarcinoma |
0.022519916 |
Sensitive |
| ENSG00000226876.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.011312653 |
Sensitive |
| ENSG00000230068.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.038609198 |
Sensitive |
| ENSG00000235802.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.017775072 |
Sensitive |
| ENSG00000237687.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.02693288 |
Sensitive |
| ENSG00000246859.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.007795986 |
Sensitive |
| ENSG00000250948.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.048792604 |
Sensitive |
| ENSG00000251169.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.04828754 |
Sensitive |
| ENSG00000259548.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.044296756 |
Sensitive |
| ENSG00000260120.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.017838 |
Sensitive |
| ENSG00000262223.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.005253403 |
Sensitive |
| ENSG00000266599.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.036650281 |
Sensitive |
| ENSG00000269927.1 |
Methotrexate |
Pancreatic adenocarcinoma |
0.030320971 |
Sensitive |
| ENSG00000270022.2 |
Methotrexate |
Pancreatic adenocarcinoma |
0.036824438 |
Sensitive |
| ENSG00000188206.5 |
Methotrexate |
Sarcoma |
0.047992894 |
Sensitive |
| ENSG00000203288.3 |
Methotrexate |
Sarcoma |
0.02493029 |
Sensitive |
| ENSG00000204791.4 |
Methotrexate |
Sarcoma |
0.012899766 |
Sensitive |
| ENSG00000205913.2 |
Methotrexate |
Sarcoma |
0.009696516 |
Sensitive |
| ENSG00000214105.2 |
Methotrexate |
Sarcoma |
0.021499647 |
Sensitive |
| ENSG00000218018.2 |
Methotrexate |
Sarcoma |
0.036166961 |
Sensitive |
| ENSG00000220161.4 |
Methotrexate |
Sarcoma |
0.01892995 |
Sensitive |
| ENSG00000223356.1 |
Methotrexate |
Sarcoma |
0.046369915 |
Sensitive |
| ENSG00000224533.3 |
Methotrexate |
Sarcoma |
0.003495908 |
Sensitive |
| ENSG00000224699.4 |
Methotrexate |
Sarcoma |
0.003465786 |
Sensitive |
| ENSG00000225083.1 |
Methotrexate |
Sarcoma |
0.037747508 |
Sensitive |
| ENSG00000225302.1 |
Methotrexate |
Sarcoma |
0.015031845 |
Sensitive |
| ENSG00000225393.1 |
Methotrexate |
Sarcoma |
0.046024999 |
Sensitive |
| ENSG00000226386.1 |
Methotrexate |
Sarcoma |
0.019540107 |
Sensitive |
| ENSG00000226913.1 |
Methotrexate |
Sarcoma |
0.02473444 |
Sensitive |
| ENSG00000227117.2 |
Methotrexate |
Sarcoma |
0.045262598 |
Sensitive |
| ENSG00000227218.3 |
Methotrexate |
Sarcoma |
0.029718295 |
Sensitive |
| ENSG00000229587.2 |
Methotrexate |
Sarcoma |
0.048212119 |
Sensitive |
| ENSG00000230736.2 |
Methotrexate |
Sarcoma |
0.046493772 |
Sensitive |
| ENSG00000231057.3 |
Methotrexate |
Sarcoma |
0.046167686 |
Sensitive |
| ENSG00000231616.4 |
Methotrexate |
Sarcoma |
0.022007753 |
Sensitive |
| ENSG00000232224.1 |
Methotrexate |
Sarcoma |
0.018110187 |
Sensitive |
| ENSG00000232412.1 |
Methotrexate |
Sarcoma |
0.049597764 |
Sensitive |
| ENSG00000235106.4 |
Methotrexate |
Sarcoma |
0.023688176 |
Sensitive |
| ENSG00000235475.1 |
Methotrexate |
Sarcoma |
0.015415384 |
Sensitive |
| ENSG00000236206.1 |
Methotrexate |
Sarcoma |
0.036947465 |
Sensitive |
| ENSG00000237301.1 |
Methotrexate |
Sarcoma |
0.042371543 |
Sensitive |
| ENSG00000240137.1 |
Methotrexate |
Sarcoma |
0.007488455 |
Sensitive |
| ENSG00000241288.3 |
Methotrexate |
Sarcoma |
0.016997163 |
Sensitive |
| ENSG00000247679.2 |
Methotrexate |
Sarcoma |
0.007899837 |
Sensitive |
| ENSG00000248473.1 |
Methotrexate |
Sarcoma |
0.005169874 |
Sensitive |
| ENSG00000248671.3 |
Methotrexate |
Sarcoma |
0.026392064 |
Sensitive |
| ENSG00000248787.1 |
Methotrexate |
Sarcoma |
0.031177369 |
Sensitive |
| ENSG00000250107.1 |
Methotrexate |
Sarcoma |
0.031137886 |
Sensitive |
| ENSG00000250132.2 |
Methotrexate |
Sarcoma |
0.007916601 |
Sensitive |
| ENSG00000250286.1 |
Methotrexate |
Sarcoma |
0.049511157 |
Sensitive |
| ENSG00000250451.1 |
Methotrexate |
Sarcoma |
0.031741814 |
Sensitive |
| ENSG00000250582.1 |
Methotrexate |
Sarcoma |
0.005592761 |
Sensitive |
| ENSG00000253347.1 |
Methotrexate |
Sarcoma |
0.015138318 |
Sensitive |
| ENSG00000253562.1 |
Methotrexate |
Sarcoma |
0.033917734 |
Sensitive |
| ENSG00000254389.2 |
Methotrexate |
Sarcoma |
0.039690998 |
Sensitive |
| ENSG00000254419.1 |
Methotrexate |
Sarcoma |
0.005752426 |
Sensitive |
| ENSG00000254648.1 |
Methotrexate |
Sarcoma |
0.007457237 |
Sensitive |
| ENSG00000254833.1 |
Methotrexate |
Sarcoma |
0.009345671 |
Sensitive |
| ENSG00000255337.1 |
Methotrexate |
Sarcoma |
0.043926088 |
Sensitive |
| ENSG00000255857.1 |
Methotrexate |
Sarcoma |
0.023119062 |
Sensitive |
| ENSG00000256742.1 |
Methotrexate |
Sarcoma |
0.010720053 |
Sensitive |
| ENSG00000256824.1 |
Methotrexate |
Sarcoma |
0.009695465 |
Sensitive |
| ENSG00000257135.1 |
Methotrexate |
Sarcoma |
0.019204958 |
Sensitive |
| ENSG00000258048.1 |
Methotrexate |
Sarcoma |
0.021165281 |
Sensitive |
| ENSG00000258199.1 |
Methotrexate |
Sarcoma |
0.024795802 |
Sensitive |
| ENSG00000259635.1 |
Methotrexate |
Sarcoma |
0.033544643 |
Sensitive |
| ENSG00000259818.1 |
Methotrexate |
Sarcoma |
0.03946527 |
Sensitive |
| ENSG00000260316.1 |
Methotrexate |
Sarcoma |
0.025539581 |
Sensitive |
| ENSG00000260625.1 |
Methotrexate |
Sarcoma |
0.030933275 |
Sensitive |
| ENSG00000260637.1 |
Methotrexate |
Sarcoma |
0.023037172 |
Sensitive |
| ENSG00000260648.2 |
Methotrexate |
Sarcoma |
0.035051971 |
Sensitive |
| ENSG00000260927.1 |
Methotrexate |
Sarcoma |
0.040000676 |
Sensitive |
| ENSG00000261126.3 |
Methotrexate |
Sarcoma |
0.017205829 |
Sensitive |
| ENSG00000261434.1 |
Methotrexate |
Sarcoma |
0.024151383 |
Sensitive |
| ENSG00000261584.1 |
Methotrexate |
Sarcoma |
0.033114762 |
Sensitive |
| ENSG00000262202.3 |
Methotrexate |
Sarcoma |
0.037355026 |
Sensitive |
| ENSG00000262585.1 |
Methotrexate |
Sarcoma |
0.000458182 |
Sensitive |
| ENSG00000262686.1 |
Methotrexate |
Sarcoma |
0.038483143 |
Sensitive |
| ENSG00000263069.1 |
Methotrexate |
Sarcoma |
0.042346151 |
Sensitive |
| ENSG00000264270.1 |
Methotrexate |
Sarcoma |
0.03606925 |
Sensitive |
| ENSG00000264304.1 |
Methotrexate |
Sarcoma |
0.01146191 |
Sensitive |
| ENSG00000264940.2 |
Methotrexate |
Sarcoma |
0.01820904 |
Sensitive |
| ENSG00000265688.1 |
Methotrexate |
Sarcoma |
0.019264973 |
Sensitive |
| ENSG00000265692.1 |
Methotrexate |
Sarcoma |
0.040090957 |
Sensitive |
| ENSG00000266079.2 |
Methotrexate |
Sarcoma |
0.029451173 |
Sensitive |
| ENSG00000266969.1 |
Methotrexate |
Sarcoma |
0.009956551 |
Sensitive |
| ENSG00000267108.1 |
Methotrexate |
Sarcoma |
0.015466627 |
Sensitive |
| ENSG00000267143.1 |
Methotrexate |
Sarcoma |
0.030422722 |
Sensitive |
| ENSG00000267212.1 |
Methotrexate |
Sarcoma |
0.022611279 |
Sensitive |
| ENSG00000267277.1 |
Methotrexate |
Sarcoma |
0.041798505 |
Sensitive |
| ENSG00000267475.1 |
Methotrexate |
Sarcoma |
0.038672854 |
Sensitive |
| ENSG00000267543.1 |
Methotrexate |
Sarcoma |
0.014776928 |
Sensitive |
| ENSG00000267546.2 |
Methotrexate |
Sarcoma |
0.010520553 |
Sensitive |
| ENSG00000267651.1 |
Methotrexate |
Sarcoma |
0.024353543 |
Sensitive |
| ENSG00000268006.1 |
Methotrexate |
Sarcoma |
0.029860439 |
Sensitive |
| ENSG00000268066.1 |
Methotrexate |
Sarcoma |
0.010289961 |
Sensitive |
| ENSG00000268164.1 |
Methotrexate |
Sarcoma |
0.002869766 |
Sensitive |
| ENSG00000268401.1 |
Methotrexate |
Sarcoma |
0.035203435 |
Sensitive |
| ENSG00000269172.1 |
Methotrexate |
Sarcoma |
0.002793093 |
Sensitive |
| ENSG00000269486.1 |
Methotrexate |
Sarcoma |
0.022211949 |
Sensitive |
| ENSG00000270605.1 |
Methotrexate |
Sarcoma |
0.026219107 |
Sensitive |
| ENSG00000270681.1 |
Methotrexate |
Sarcoma |
0.047853064 |
Sensitive |
| ENSG00000271199.1 |
Methotrexate |
Sarcoma |
0.038280313 |
Sensitive |
| ENSG00000272076.1 |
Methotrexate |
Sarcoma |
0.049773222 |
Sensitive |
| ENSG00000272275.1 |
Methotrexate |
Sarcoma |
0.003516844 |
Sensitive |
| ENSG00000272301.1 |
Methotrexate |
Sarcoma |
0.048978213 |
Sensitive |
| ENSG00000272386.1 |
Methotrexate |
Sarcoma |
0.031435023 |
Sensitive |
| ENSG00000272523.1 |
Methotrexate |
Sarcoma |
0.023327273 |
Sensitive |
| ENSG00000272696.1 |
Methotrexate |
Sarcoma |
0.018487965 |
Sensitive |
| ENSG00000273133.1 |
Methotrexate |
Sarcoma |
0.009581091 |
Sensitive |
| ENSG00000273176.1 |
Methotrexate |
Sarcoma |
0.01233571 |
Sensitive |
| ENSG00000273271.1 |
Methotrexate |
Sarcoma |
0.047302349 |
Sensitive |
| ENSG00000273384.1 |
Methotrexate |
Sarcoma |
0.001306594 |
Sensitive |
| ENSG00000177112.3 |
Methotrexate |
Skin cutaneous melanoma |
0.04271866 |
Sensitive |
| ENSG00000186594.8 |
Methotrexate |
Skin cutaneous melanoma |
0.042290102 |
Sensitive |
| ENSG00000189238.4 |
Methotrexate |
Skin cutaneous melanoma |
0.035836224 |
Sensitive |
| ENSG00000225703.1 |
Methotrexate |
Skin cutaneous melanoma |
0.013617483 |
Sensitive |
| ENSG00000226088.1 |
Methotrexate |
Skin cutaneous melanoma |
0.005254197 |
Sensitive |
| ENSG00000226312.3 |
Methotrexate |
Skin cutaneous melanoma |
0.039148636 |
Sensitive |
| ENSG00000227496.1 |
Methotrexate |
Skin cutaneous melanoma |
0.013530975 |
Sensitive |
| ENSG00000228741.2 |
Methotrexate |
Skin cutaneous melanoma |
0.018903888 |
Sensitive |
| ENSG00000229656.2 |
Methotrexate |
Skin cutaneous melanoma |
0.049498898 |
Sensitive |
| ENSG00000230058.1 |
Methotrexate |
Skin cutaneous melanoma |
0.042314291 |
Sensitive |
| ENSG00000230303.1 |
Methotrexate |
Skin cutaneous melanoma |
0.024490603 |
Sensitive |
| ENSG00000231119.2 |
Methotrexate |
Skin cutaneous melanoma |
0.047809238 |
Sensitive |
| ENSG00000232053.2 |
Methotrexate |
Skin cutaneous melanoma |
0.019274272 |
Sensitive |
| ENSG00000232151.5 |
Methotrexate |
Skin cutaneous melanoma |
0.024949664 |
Sensitive |
| ENSG00000233610.1 |
Methotrexate |
Skin cutaneous melanoma |
0.019091796 |
Sensitive |
| ENSG00000233862.1 |
Methotrexate |
Skin cutaneous melanoma |
0.021536975 |
Sensitive |
| ENSG00000234478.1 |
Methotrexate |
Skin cutaneous melanoma |
0.006726821 |
Sensitive |
| ENSG00000235246.1 |
Methotrexate |
Skin cutaneous melanoma |
0.024941467 |
Sensitive |
| ENSG00000235313.1 |
Methotrexate |
Skin cutaneous melanoma |
0.015854485 |
Sensitive |
| ENSG00000235635.1 |
Methotrexate |
Skin cutaneous melanoma |
0.043641903 |
Sensitive |
| ENSG00000236472.1 |
Methotrexate |
Skin cutaneous melanoma |
0.029926083 |
Sensitive |
| ENSG00000236526.1 |
Methotrexate |
Skin cutaneous melanoma |
0.034950559 |
Sensitive |
| ENSG00000236581.4 |
Methotrexate |
Skin cutaneous melanoma |
0.031228639 |
Sensitive |
| ENSG00000237463.1 |
Methotrexate |
Skin cutaneous melanoma |
0.033930956 |
Sensitive |
| ENSG00000237502.2 |
Methotrexate |
Skin cutaneous melanoma |
0.009093628 |
Sensitive |
| ENSG00000237595.2 |
Methotrexate |
Skin cutaneous melanoma |
0.035588172 |
Sensitive |
| ENSG00000237807.3 |
Methotrexate |
Skin cutaneous melanoma |
0.034231485 |
Sensitive |
| ENSG00000239552.2 |
Methotrexate |
Skin cutaneous melanoma |
0.038743148 |
Sensitive |
| ENSG00000239705.1 |
Methotrexate |
Skin cutaneous melanoma |
0.013713934 |
Sensitive |
| ENSG00000239828.2 |
Methotrexate |
Skin cutaneous melanoma |
0.015061457 |
Sensitive |
| ENSG00000240254.1 |
Methotrexate |
Skin cutaneous melanoma |
0.018260471 |
Sensitive |
| ENSG00000243533.2 |
Methotrexate |
Skin cutaneous melanoma |
0.026466608 |
Sensitive |
| ENSG00000244124.1 |
Methotrexate |
Skin cutaneous melanoma |
0.017928454 |
Sensitive |
| ENSG00000245479.2 |
Methotrexate |
Skin cutaneous melanoma |
0.009599698 |
Sensitive |
| ENSG00000249356.1 |
Methotrexate |
Skin cutaneous melanoma |
0.010133349 |
Sensitive |
| ENSG00000251034.1 |
Methotrexate |
Skin cutaneous melanoma |
0.04925412 |
Sensitive |
| ENSG00000251194.2 |
Methotrexate |
Skin cutaneous melanoma |
0.027521583 |
Sensitive |
| ENSG00000253408.1 |
Methotrexate |
Skin cutaneous melanoma |
0.020373001 |
Sensitive |
| ENSG00000254204.1 |
Methotrexate |
Skin cutaneous melanoma |
0.029583346 |
Sensitive |
| ENSG00000254610.1 |
Methotrexate |
Skin cutaneous melanoma |
0.032897402 |
Sensitive |
| ENSG00000254964.1 |
Methotrexate |
Skin cutaneous melanoma |
0.008471997 |
Sensitive |
| ENSG00000256690.1 |
Methotrexate |
Skin cutaneous melanoma |
0.004241078 |
Sensitive |
| ENSG00000257354.1 |
Methotrexate |
Skin cutaneous melanoma |
0.008593434 |
Sensitive |
| ENSG00000257910.1 |
Methotrexate |
Skin cutaneous melanoma |
0.048121061 |
Sensitive |
| ENSG00000258701.1 |
Methotrexate |
Skin cutaneous melanoma |
0.027489025 |
Sensitive |
| ENSG00000259542.1 |
Methotrexate |
Skin cutaneous melanoma |
0.043940715 |
Sensitive |
| ENSG00000259709.1 |
Methotrexate |
Skin cutaneous melanoma |
0.030527215 |
Sensitive |
| ENSG00000260364.1 |
Methotrexate |
Skin cutaneous melanoma |
0.033170818 |
Sensitive |
| ENSG00000260400.1 |
Methotrexate |
Skin cutaneous melanoma |
0.008077585 |
Sensitive |
| ENSG00000260436.1 |
Methotrexate |
Skin cutaneous melanoma |
0.019652119 |
Sensitive |
| ENSG00000260834.1 |
Methotrexate |
Skin cutaneous melanoma |
0.021163096 |
Sensitive |
| ENSG00000260895.1 |
Methotrexate |
Skin cutaneous melanoma |
0.02539417 |
Sensitive |
| ENSG00000261002.1 |
Methotrexate |
Skin cutaneous melanoma |
0.00196525 |
Sensitive |
| ENSG00000262171.1 |
Methotrexate |
Skin cutaneous melanoma |
0.013273667 |
Sensitive |
| ENSG00000262721.1 |
Methotrexate |
Skin cutaneous melanoma |
0.047499403 |
Sensitive |
| ENSG00000264269.1 |
Methotrexate |
Skin cutaneous melanoma |
0.01275363 |
Sensitive |
| ENSG00000265702.1 |
Methotrexate |
Skin cutaneous melanoma |
0.031340704 |
Sensitive |
| ENSG00000266993.1 |
Methotrexate |
Skin cutaneous melanoma |
0.045817818 |
Sensitive |
| ENSG00000268520.1 |
Methotrexate |
Skin cutaneous melanoma |
0.002792996 |
Sensitive |
| ENSG00000270031.1 |
Methotrexate |
Skin cutaneous melanoma |
0.026798135 |
Sensitive |
| ENSG00000270105.1 |
Methotrexate |
Skin cutaneous melanoma |
0.049168641 |
Sensitive |
| ENSG00000270462.1 |
Methotrexate |
Skin cutaneous melanoma |
0.04077555 |
Sensitive |
| ENSG00000271327.1 |
Methotrexate |
Skin cutaneous melanoma |
0.03165356 |
Sensitive |
| ENSG00000271344.1 |
Methotrexate |
Skin cutaneous melanoma |
0.014534775 |
Sensitive |
| ENSG00000271646.1 |
Methotrexate |
Skin cutaneous melanoma |
0.00738039 |
Sensitive |
| ENSG00000271709.1 |
Methotrexate |
Skin cutaneous melanoma |
0.048308252 |
Sensitive |
| ENSG00000272072.1 |
Methotrexate |
Skin cutaneous melanoma |
0.012955246 |
Sensitive |
| ENSG00000272142.1 |
Methotrexate |
Skin cutaneous melanoma |
0.045263152 |
Sensitive |
| ENSG00000272144.1 |
Methotrexate |
Skin cutaneous melanoma |
0.007765488 |
Sensitive |
| ENSG00000272861.1 |
Methotrexate |
Skin cutaneous melanoma |
0.01376861 |
Sensitive |
| ENSG00000272970.1 |
Methotrexate |
Skin cutaneous melanoma |
0.044808986 |
Sensitive |
| ENSG00000273257.1 |
Methotrexate |
Skin cutaneous melanoma |
0.01652321 |
Sensitive |
| ENSG00000273451.1 |
Methotrexate |
Skin cutaneous melanoma |
0.025117922 |
Sensitive |
| ENSG00000273454.1 |
Methotrexate |
Skin cutaneous melanoma |
0.04676829 |
Sensitive |
